DEF 14A 1 ipgphotonicsproxy2022.htm DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Rule 14a-101)
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No.__ )

þ | Filed by the Registrant | ¨ | Filed by a Party other than the Registrant

CHECK THE APPROPRIATE BOX:
¨ |  | Preliminary Proxy Statement
¨ |  | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
þ |  | Definitive Proxy Statement
¨ |  | Definitive Additional Materials
¨ |  | Soliciting Material Pursuant to Section 240.14a-12

IPG Photonics Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):
þ |  | No fee required.
¨ |  | Fee paid previously with preliminary materials.
¨ |  | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

2022 Annual Letter
It has been a seminal year for IPG in many different ways. I am pleased to report that we delivered record revenue in 2021 despite the continued uncertainty in the global operating environment, supply chain challenges and the COVID-19 outbreaks around the world. We also successfully navigated a CEO transition in 2021 and I feel extremely privileged that the Board chose me as the next CEO of this great company. We were deeply saddened by the passing of IPG founder and former CEO Dr. Valentin P. Gapontsev. It was a tremendous loss for IPG and the laser photonics world, but we are proud to continue to implement his strategic vision and successful innovations. We are executing on our strategy to achieve a better balance in our business by pursuing profitable growth opportunities in electric vehicle applications, renewable energy, handheld welding, medical markets and ultrafast lasers, diversifying IPG away from the highly competitive high power cutting market in China. We delivered excellent results as our revenue increased 22% year over year in 2021, surpassing the previous record revenue delivered in 2018. We benefited from improved demand for our lasers in Europe, North America and China, driven by increased economic activity, fiber laser adoption and regionalization of supply chains that is driving local investments in new equipment and manufacturing capacity. We saw strong growth in welding, marking, 3D printing, cleaning and medical applications. Sales of high power lasers benefited from an increase in order volumes in cutting applications in Europe and North America. Our high power lasers and optical heads can deliver significant productivity improvements, electrical efficiency, flexibility and ease of use and integration as well as lowest total cost of ownership and global support, unmatched by other lasers and non-laser tools. Our welding and foil cutting solutions are widely accepted as a standard tool in the manufacturing of electric vehicles batteries around the world. Furthermore, I would like to highlight our exceptional growth in welding this year, driven by higher demand for AMB lasers used in EV battery manufacturing and the introduction of LightWELD, our handheld welder. Both products are examples of IPG's focus on innovation and ability to deliver solutions to our customers that expand our total available market. We were also pleased with the growth we are seeing in medium power, pulsed and QCW lasers, which are primarily driven by higher demand in emerging growth applications. Our medical business delivered record revenue in 2021 as our gold standard urology lasers and disposable fibers that represent a significant recurring revenue opportunity continued to gain acceptance. |  |
Delivered record revenue in 2021 despite the continued uncertainty in the global operating environment
Focus on innovation and ability to deliver solutions to our customers that expand our total available market

1

2022 Annual Letter

IPG is well positioned to benefit from global macro trends such as automation and miniaturization, as well as increasing attention on sustainability, renewable energy and energy efficiency. We expect that electric vehicle and solar cell manufacturing will benefit from multi-year investment cycles, supporting IPG sales into these markets. Focus on sustainability and efficiency as well as some recent energy shortages and higher energy prices are driving an increased interest for our ECO lasers that provide wall-plug efficiency of greater than 50% and can help to meaningfully reduce the environmental impact and energy costs for medium and large industrial manufacturers. We remain committed to our focus on innovation and further aligning our R&D, market development, sales and technical support functions. This will allow us to continue to provide new leading-edge solutions for our customers, helping drive efficiency and productivity in their operations and making our fiber laser technology the tool of choice in many different markets. Turning to this year, we are of course following the tragic situation in Ukraine closely and hope for a swift end to this conflict. To be clear, our business and ability to fulfil orders are not heavily reliant on our supply chain from Russia. However, we are taking all necessary precautions to mitigate potential risks posed by sanctions. In early March, we announced that we will be executing on our contingency plans to increase production of key optical and other components in the U.S. and Europe and reduce our reliance on Russian operations. These efforts are well underway. Importantly, our strong cash flow generations and balance sheet allow us to support R&D investments and capital expenditures, focusing on long-term objectives, diversifying our business with new products, finding new markets, driving innovations to maintain and increase margins and to return capital to shareholders through share repurchases. We finished the year with approximately $1.5 billion net cash and ample liquidity, spent $140 million on research and development and $123 million on capital expenditures. We also repurchased $135 million worth of stock. The IPG Board authorized $200 million in additional share repurchases. Including this new program, the Board has authorized more than half a billion dollars in stock repurchases over the last three years. Our strong balance sheet also provides us with flexibility in responding to disruptions and uncertainty in the operating environment and allows us to emerge from these challenges a stronger company.
EUGENE SCHERBAKOV, PH.D. Chief Executive Officer April 1, 2022 |  |

2 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Notice of Annual Meeting of Stockholders

DATE AND TIME May 24, 2022 10:00 AM (Eastern Time) | LOCATION IPG Photonics Corporation 50 Old Webster Road Oxford, Massachusetts 01540 | WHO CAN VOTE Only stockholders of record at the close of business on April 1, 2022 may vote at the Annual Meeting

Voting Items

Proposals | Board Vote Recommendation | For Further Details
1 | Election of ten directors named in this proxy statement | ü FOR each director nominee |  | Page 11
2 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2022 | ü FOR |  | Page 61

Stockholders will also transact any other business that may properly come before the meeting.
You may vote on these matters in person or by proxy. Whether or not you plan to attend the Annual Meeting, we ask that you promptly vote your shares.
By order of the Board of Directors
IPG PHOTONICS CORPORATION
ANGELO P. LOPRESTI
Secretary
April 1, 2022
Oxford, Massachusetts
How to Vote

INTERNET Go to www.investorvote.com/ipgp or scan the QR code contained in the attached proxy card | TELEPHONE 1-800-652-VOTE (8683) | MAIL Mark, sign, date and promptly mail the enclosed proxy card in the postage-paid envelope

As permitted by the rules of the United States Securities and Exchange Commission (the “SEC”), we are making this Proxy Statement and Annual Report on Form 10-K available to stockholders electronically via the Internet at investor.ipgphotonics.com. On or about April 14, 2022, we will mail to most of our stockholders a notice (the “Notice”) containing instructions on how to access this Proxy Statement and our Annual Report and to vote via the Internet or by telephone. Other stockholders, in accordance with their prior requests, will receive e-mail notification of how to access our proxy materials and vote via the Internet or by telephone, or will be mailed paper copies of our proxy materials and a proxy card on or about April 14, 2022.

3

Proxy Statement Summary
This summary highlights information available within our proxy statement. You should consider all of the information available in this proxy statement (the "Proxy Statement") and our Annual Report on Form 10-K for fiscal year 2021 ("Annual Report") filed with the SEC on February 22, 2022, prior to voting your shares. Page references are supplied to help you find further information in this Proxy Statement. In this Proxy Statement, the terms "IPG", the "Company", "we" and "our" refer to IPG Photonics Corporation.

Company Overview

IPG Photonics Corporation is a world leader in fiber laser technology, enabling greater precision, higher productivity and more flexible production for industrial applications and other diverse end markets. The Company has a vertically-integrated business model, producing key components of its technology in-house, enabling more powerful and efficient solutions with rapid ongoing cost reduction. Within industrial applications, automated production and miniaturization trends are driving replacement of mechanical machine tools with IPG laser-based solutions. In other end markets, IPG is introducing new products that increase our addressable market while diversifying end-market exposure.

Performance Highlights

IPG delivered record revenue in 2021 despite the continued uncertainty in the global operating environment as well as a softer demand and increased competition in the cutting market in China, particularly in the second half of the year. Revenue increased 22% year over year benefiting from growth in Europe, North America and China. We benefited from our focus on new products and opportunities that diversify our revenue and provide a better balance in our business. We improved our margins and generated strong cash flow from operations.
Financial Highlights

NET SALES | OPERATING INCOME

•Materials processing sales accounted for 91% of total revenue and increased 22%, driven by increased sales in welding, marking, 3D printing and cleaning applications. Other applications revenue increased 15% year over year, driven by increased demand for lasers used in medical procedures and advanced applications.
•Gross margin increased to 47.7% in 2021 from 44.9% in 2020, driven by decreased manufacturing costs as a percentage of sales and the absence of additional inventory charges.
•Sales outside of China increased to 69% of our total revenue in the fourth quarter of 2021, showing progress in achieving more geographic balance in our business.
•Sales of emerging growth products contributed 38% of total revenue in the fourth quarter compared to 27% in the fourth quarter last year.
•Strong balance sheet with cash, cash equivalents and short-term investments of $1.5 billion at December 31, 2021.
4 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Proxy Statement Summary

Voting Items

Proposal 1 | Election of Ten Directors The Board recommends a vote FOR each director nominee named in this Proxy Statement.
| See page 11

Director Nominees
The following provides summary information about each director nominee for our Board of Directors (the "Board").

|  |  |  | Committee Membership
| Name and Principal Occupation | Age | Director Since | AC | CC | NCGC
| John R. Peeler IND, Non-Executive Chair of the Board |  |  |  |  |
Former Chairman and CEO, Veeco Instruments, Inc. | 67 | 2012 |  | ● | ●
| Eugene A. Scherbakov, Ph.D. |  |  |  |  |
Chief Executive Officer | 74 | 2000 |  |  |
| Michael C. Child IND |  |  |  |  |
Senior Advisor, T.A. Associates, Inc. | 67 | 2000 |  |  | ●
| Jeanmarie F. Desmond IND |  |  |  |  |
Former EVP and CFO, DuPont de Nemours, Inc. | 55 | 2021 | ● |  |
| Gregory P. Dougherty IND |  |  |  |  |
Former CEO, Oclaro, Inc. | 62 | 2019 | ● | ● |
| Eric Meurice IND |  |  |  |  |
Former President, CEO and Chairman, ASML Holding NV | 65 | 2014 |  | ● | ●
| Natalia Pavlova |  |  |  |  |
Significant stockholder | 43 | 2021 |  |  |
| Thomas J. Seifert IND |  |  |  |  |
Chief Financial Officer, Cloudflare, Inc. | 58 | 2014 | ● |  | ●
| Felix Stukalin |  |  |  |  |
Senior Vice President, Chief Operating Officer | 60 | 2022 |  |  |
| Agnes Tang IND |  |  |  |  |
Partner, Ducera Partners LLC | 48 | 2022 |  |  |

AC Audit Committee | ● | Chair
CC Compensation Committee | ● | Member
NCGC Nominating and Corporate Governance Committee |  |
IND Independent director under Nasdaq and SEC rules |  |

5

Proxy Statement Summary
Board Snapshot

DIRECTOR INDEPENDENCE | BALANCED TENURE | AGE | DIVERSITY
7/10 directors are independent* | 8 years Average Tenure | 60 years Average Age | 30% Female

* Audit, Compensation and Nominating and Corporate Governance Committees are composed entirely of independent directors.
Skills and Experience

| Lasers and Technology |  |  |  | Risk Management |
| Financial Literacy |  |  |  | Executive Leadership |
| Global Business |  |  |  | Other Public Company Boards |
| Manufacturing and Operating |  |  |  | Non-Corporate Experience |
| Business Development and M&A |  |  |  |  |

6 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Proxy Statement Summary
Corporate Governance Highlights

ü Separated roles of Chairman and CEO in May 2021 ü Appointed first non-executive Chair of the Board in October 2021 ü Board policy requires external director candidate pool to include diversity of gender and/or race/ethnicity ü Stockholder proxy access right adopted in March 2019 ü Director majority voting policy adopted in October 2018 ü Supermajority of independent directors and 100% independent Board committees | ü Active Board refreshment: 3 female directors added in last eighteen months; 5 new directors in 4 years ü 60% of Board members were born outside of the U.S.A., bringing international perspectives ü 30% of Board members are women ü Single class of voting stock and no supermajority voting provisions ü Annual election of all directors ü Stockholder right to act by written consent | ü 81% of director compensation at risk based upon stock performance ü Annual Board performance evaluations ü Robust director and executive officer stock ownership guidelines ü Anti-hedging policy applicable to all employees and directors ü Adopted ESG oversight framework to clearly allocate responsibilities among Board and standing committees in February 2022

Stockholder Engagement
We value the views of our stockholders and we believe that building positive relationships with our stockholders is critical to our long-term success. Our investor communications and outreach include quarterly conference calls, follow-up conversations with our investors, periodic site visits, participation in investor conferences, investor sentiment and materiality assessments. Our quarterly conference calls and presentations at investor conferences are open to the public and are available live and as archived webcasts on our website. To help management and the Board understand and consider the issues that matter most to our stockholders, we periodically engage with our stockholders on a range of topics including performance, executive compensation, governance and sustainability matters; our Board has been responsive to feedback it has received. Following investor requests for greater diversity in director recruitment, the Board added three female members to the Board over the last 18 months and the Board formally adopted a written policy to require external director candidate pools to include candidates with diversity of gender and/or race/ethnicity.
Governance Features of our Executive Compensation Program

PRACTICES WE EMPLOY |  | PRACTICES WE AVOID
ü Align our officer pay with performance ü Balance annual and long-term incentives ü Use long-term incentives to link executive pay to company performance ü Cap incentive award payouts ü Maximize stockholder value while mitigating risk ü Independent compensation consultant ü Robust stock ownership requirements ü Clawbacks on executive compensation |  | û No guaranteed annual bonuses û No SERP or pension û No excise tax gross-ups û No excessive perquisites û Prohibit hedging of Company stock û No severance for “cause” terminations û No single-trigger change in control provisions û No stock option repricing without stockholder approval û Pledging of Company stock is limited

7

Proxy Statement Summary
2021 Executive Compensation Highlights
As further discussed in Compensation Discussion and Analysis starting on page 37, the guiding principles of our executive compensation philosophy are pay-for-performance, accountability for annual and long-term performance, alignment with stockholders’ interests, and providing competitive pay to attract and retain executives. The 2021 compensation program for our named executive officers ("NEOs") has three primary components: annual base salary, annual cash incentives and long-term equity incentives. The annual cash incentive amounts are presented based on actual amounts earned under the annual incentive plan for services rendered in 2021. Figures below for Dr. Scherbakov reflect his compensation as CEO on an annualized basis for 2021. He assumed the role in May 2021. Figures below exclude the former CEO, Dr. Valentin Gapontsev, who did not receive equity grants due to his significant ownership of Company stock.

| Fixed |  |  | At-risk |  |  |  |
| Base Salary |  | Annual Cash Incentive |  | Long-Term Equity Incentives
Pay Mix | CEO | OTHER NEOs |  | CEO | OTHER NEOs |  | CEO | OTHER NEOs
|  |  |  |  |  |  | PSUs (Performance Based) & RSUs (Service Based)
Performance | •Executive base salaries increased modestly in 2021 after remaining stable since January 2018 |  | •Record annual revenue led to performance in excess of targets for 2021, despite macroeconomic uncertainty and challenges from ongoing COVID-19 pandemic |  | •PSUs awarded in 2018 and 2019 based on relative TSR did not result in payouts upon vesting in March 2021 and 2022, respectively
Objectives | •Provide a competitive fixed component to attract and retain talented and experienced executives |  | •Variable cash compensation opportunity is based upon annual net sales and profitability against threshold, target and maximum performance goals •Additional compensation opportunities are based upon individual performance |  | •Align interests of our executives and stockholders by motivating executive officers to increase long-term stockholder value •PSU awards provide incentives and are earned based on IPG’s total stockholder return relative to a comparable stock index and an operating metric based upon operating cash flow •Service-based RSUs awards vest over four years providing long-term retention and alignment to stockholder value

8 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Proxy Statement Summary
Compensation Alignment with Stockholder Interests and Performance

•Annual cash incentive payouts are capped and have challenging performance goals linked to key financial performance metrics •Long-term equity incentives are aligned with long-term stockholder value creation •Over 80% of current NEO compensation in 2021 was performance based •Executives exceed stock ownership guidelines, aligning with interests of stockholders •After considering the results of the 2020 vote, the Compensation Committee determined to maintain its pay philosophy and practices. |  | Say-on-pay approval during last stockholder vote in 2020

Proposal 2 | Ratify Deloitte & Touche LLP as our Independent Registered Public Accounting Firm for 2022 The Board recommends a vote FOR this proposal.
| See page 61

The Audit Committee has sole authority to appoint and replace the Company’s independent registered public accounting firm, which reports directly to the Audit Committee, and is directly responsible for its compensation and oversight of its work. The Audit Committee conducted its annual evaluation of Deloitte & Touche LLP and, after assessing the performance and independence of Deloitte & Touche LLP, the Audit Committee concluded that the best course of action was to reappoint Deloitte & Touche LLP as our independent external auditor for 2022.
We are asking you to ratify this appointment. If stockholders fail to ratify the appointment, the Audit Committee will consider it a directive to consider other accounting firms for the subsequent year.
Fees Paid to Deloitte & Touche. The fees for services provided by Deloitte & Touche LLP, member firm of Deloitte Touche Tohmatsu, and their respective affiliates, to the Company were:

| Fees
Fee Category | 2021 |  | 2020 |
Audit fees | $ | 2,230,305 |  | $ | 2,247,738 |
Audit-related fees | — | —
Tax fees | 235,195 | 145,000
All other fees | — | —
Total Fees | $ | 2,465,500 |  | $ | 2,392,738 |

In 2021 and 2020, the percentage of total fees paid to our independent registered public accounting firm for audit fees were 90% and 94%, respectively.
9

Table of Contents

| Page
202 2 ANNUAL LETTER | 1
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS | 3
PROXY STATEMENT SUMMARY | 4
PROPOSAL 1: ELECTION OF TEN DIRECTORS | 11
Director Qualifications | 11
Director Nominees | 13
Board Refreshment and Composition | 23
Board Roles and Responsibilities | 25
Board Structure | 28
Standing Committees and Board Committee Membership | 30
Board Practices, Policies and Processes | 32
Director Compensation | 35
Executive Compensation |
Compensation Committee Report | 39
Compensation Discussion and Analysis | 40
2021 Compensation of Named Executive Officers | 43
Executive Compensation Tables | 53
PROPOSAL 2: RATIFY DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 20 2 2 | 61
Audit Committee Report | 63
Common Stock Ownership | 64
Questions and Answers About the Meeting and Voting | 66
Additional Information | 70

This Proxy Statement contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Proxy Statement except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in the section titled “Risk Factors” and elsewhere in our Annual Report and other filings with the SEC. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

10 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Proposal 1 | Election of Ten Directors The Board of Directors recommends a vote FOR each director nominee named in this Proxy Statement.

Director Qualifications

The Nominating and Corporate Governance Committee (the "NCGC") is responsible for identifying and evaluating nominees for director and for recommending to the Board a slate of nominees for election at the Annual Meeting. The NCGC has recommended, and the Board has approved, the following nominees for terms expiring at the annual meeting to be held in 2023, until a successor is elected and qualified or until his or her earlier death, resignation or removal and, unless otherwise marked, a proxy will be voted for such nominees: Mr. Peeler, Dr. Scherbakov, Mr. Child, Ms. Desmond, Mr. Dougherty, Mr. Meurice, Ms. Pavlova, Mr. Seifert, Mr. Stukalin and Ms. Tang. All of the director nominees set forth in our proxy card have consented to being named in this Proxy Statement and to serving if elected. For more information regarding the nominees for director, see Director Nominees below.
In considering each director nominee and the composition of the Board as a whole, the NCGC evaluates members based on their expertise and diverse perspectives, experiences, qualifications, attributes and skills because the NCGC believes that these attributes enable a director nominee to make significant contributions to the Board, IPG and our stockholders.
The director nominees have a mix of various skills, qualifications and attributes, some of which are listed in the table below, that enable the Board to provide effective oversight as it strives to advance our strategies and deliver returns to stockholders.

|  | Lasers and Technology |  | We have sought directors with management and operational experience in the industries in which we compete. For example, in 2019 we added a director with expertise in optical and electronics components, and telecommunications products. As a diversified technology, science-based company, directors with technology backgrounds understand the Company’s technology platforms and the importance of investing in new technologies for future growth.
|  | Financial Literacy |  | Knowledge of finance or financial reporting; experience with debt/capital market transactions and/or mergers and acquisitions strengthen the Board’s oversight of financial reporting and internal controls. Financial metrics are used to measure our performance. All directors must understand finance and financial reporting processes. Two of the Audit Committee members qualify as “audit committee financial experts.”
|  | Global Business |  | Global business experience is critical to the Company’s international operations and growth with 80% of sales from outside the U.S. in 2021. Knowledge of Asian and European business practices are valuable to understanding our business and strategy.
|  | Manufacturing and Operating |  | As a vertically-integrated company, manufacturing experience and customer service on a global scale are important to understanding the operations and capital needs of the Company.
|  | Business Development and M&A |  | We have used and will continue to use acquisitions to achieve our strategic goals. Directors with experience in business development and mergers and acquisitions provide valuable perspectives regarding process, due diligence, risk assessment and integration of potential partners.
|  | Risk Management |  | In light of the Board’s role in overseeing risk management and understanding the most significant risks facing the Company, including cybersecurity risk, we continue to require directors with experience in risk management and oversight.

11

Director Qualifications

|  | Executive Leadership |  | Significant leadership experience, including services as a CEO, senior executive, division president or functional leader within a complex organization enhances the Board’s leadership role.
|  | Other Public Company Boards |  | Directors with current or recent membership on other public company boards provide valuable perspectives in many areas including operations, strategy, governance and compensation.
|  | Non-Corporate Experience |  | Experience from backgrounds beyond the executive suite, including non-corporate backgrounds such as non-profit organizations, government and academia.

Skills and Experience | Peeler | Scherbakov | Child | Desmond | Dougherty | Meurice | Pavlova | Seifert | Stukalin |  | Tang
| Lasers and Technology | ● | ● |  |  | ● | ● |  |  | ● |  |
| Financial Literacy | ● | ● | ● | ● | ● | ● | ● | ● | ● |  | ●
| Global Business | ● | ● | ● | ● | ● | ● |  | ● | ● |  | ●
| Manufacturing and Operating | ● | ● | ● | ● | ● | ● |  | ● | ● |  |
| Business Development and M&A | ● | ● | ● | ● | ● | ● |  | ● | ● |  | ●
| Risk Management | ● | ● | ● | ● | ● | ● |  | ● | ● |  | ●
| Executive Leadership | ● | ● |  | ● | ● | ● |  | ● | ● |  |
| Other Public Company Boards | ● |  | ● | ● | ● | ● |  | ● |  |  |
| Non-Corporate Experience |  |  |  | ● |  |  | ● |  |  |  |
Tenure and Independence |  |  |  |  |  |
| Years on Board | 10 | 22 | 22 | 1 | 3 | 8 | 1 | 8 | <1 |  | <1
| Independent | ● |  | ● | ● | ● | ● |  | ● |  |  | ●
Demographics |  |  |  |  |  |
| Age | 67 | 74 | 67 | 55 | 62 | 65 | 43 | 58 | 60 |  | 48
| Gender Identity | M | M | M | F | M | M | F | M | M |  | F
| Born Outside of U.S.A. |  | ● |  |  |  | ● | ● | ● | ● |  | ●
| White | ● | ● | ● | ● | ● | ● | ● | ● | ● |  |
| Asian |  |  |  |  |  |  |  |  |  |  | ●

12 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Director Nominees

John R. Peeler
Non-Executive Chair of the Board

|  | Mr. Peeler became our non-executive Chair of the Board on October 29, 2021. Mr. Peeler was appointed to the Board in 2012 and served as the Lead Independent Director from 2017 to 2021. Mr. Peeler has been acting CEO of Jumplights Corp., a producer of LED horticultural lighting, since June 2021. He was previously the Chief Executive Officer of Veeco Instruments Inc. (“Veeco”) from July 2007 until September 2018, and Chairman or Executive Chairman of its board of directors from May 2012 until May 2020. Veeco is a developer and manufacturer of MOCVD, molecular beam epitaxy, ion beam and other advanced semiconductor processes equipment. He was Executive Vice President of JDS and President of the Communications Test & Measurement Group of JDS, which he joined upon the closing of JDS’s merger with Acterna, Inc. in August 2005. Before joining JDS, Mr. Peeler served as President and Chief Executive Officer of Acterna. In March 2021, Mr. Peeler joined the board of WaveArray Antifouling Systems, LLC, a producer of antifouling solutions, and in June 2021, he joined the board of Jumplights Corp. He has a B.S. and M.E. in Electrical Engineering from the University of Virginia. KEY ATTRIBUTES, EXPERIENCE AND SKILLS Over the course of his career, Mr. Peeler has managed several high-growth technology companies. In addition, he has developed managerial leadership skills through his former position as Chief Executive Officer of Veeco, a publicly-traded company with substantial international operations. His managerial positions have provided him with in-depth knowledge of the service needs of customers in demanding markets, including semiconductor capital equipment, various manufacturing models, research and development, marketing and sales. In these roles, he has also been responsible for attracting and incentivizing executives on his team. These experiences have provided him important insights in support of his positions as non-executive Chair and a member of the Compensation Committee and the NCGC.
AGE: 67 DIRECTOR SINCE: 2012 COMMITTEES: Compensation Committee, NCGC |
|  | Lasers and Technology | Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership | Other Public Company Boards

13

Director Nominees
Eugene A. Scherbakov, Ph.D.
Chief Executive Officer and Director

|  | Dr. Scherbakov became the Chief Executive Officer in May 2021. He has been a director since 2000. He previously served as Chief Operating Officer from February 2017, Managing Director of IPG Laser GmbH, our German subsidiary, since August 2000 and Senior Vice President-Europe since February 2013. He served as the Technical Director of IPG Laser from 1995 to August 2000. From 1983 to 1995, Dr. Scherbakov was a senior scientist in fiber optics and head of the optical communications laboratory at the General Physics Institute, Russian Academy of Science in Moscow. Dr. Scherbakov graduated from the Moscow Physics and Technology Institute with an M.S. in Physics. In addition, Dr. Scherbakov attended the Russian Academy of Science in Moscow, where he received a Ph.D. in Quantum Electronics from its Lebedev Physics Institute and a Dr.Sci. degree in Laser Physics from its General Physics Institute. KEY ATTRIBUTES, EXPERIENCE AND SKILLS As the Chief Executive Officer, Dr. Scherbakov reports to the Board and has responsibility for managing the general business and affairs of the Company. Previously as Managing Director of IPG Laser GmbH, which produces a large volume of our products and is the source of many developments in products, technology and applications, he developed extensive knowledge of the Company’s business. He applies his knowledge and experience across our many international branches. The leadership and operational expertise of Dr. Scherbakov have contributed to IPG increasing production, lowering manufacturing costs, managing risk and maintaining high margins compared to our industry peers. He also has extensive technological knowledge of fiber lasers, their components and manufacturing processes. His long-term service as an executive officer of the Company provides the Board with a detailed understanding of the Company’s operations, sales and customers.
AGE: 74 DIRECTOR SINCE: 2000 COMMITTEES: None |
|  | Lasers and Technology | Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership |

14 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Director Nominees
Michael C. Child
Independent Director

|  | Since July 1982, Mr. Child has been employed by TA Associates, Inc., a private equity investment firm, where he currently serves as Senior Advisor and, prior to January 2011, he was Managing Director. Mr. Child served previously on the boards of Finisar Corporation, a developer and manufacturer of optical subsystems and components for networks, Eagle Test Systems, Inc., a manufacturer of semiconductor test equipment, and Ultratech Inc., a developer and manufacturer of advanced packaging lithography systems and laser processing technologies. Mr. Child holds a B.S. in Electrical Engineering from the University of California at Davis and an M.B.A. from the Stanford University Graduate School of Business. From September 2011 until December 2015, Mr. Child was a Lecturer at the Stanford University Graduate School of Business. KEY ATTRIBUTES, EXPERIENCE AND SKILLS Mr. Child is an established and experienced investor, including in technology companies, from his three decades of experience at TA Associates, Inc. Over the course of his career, he has overseen numerous investments and sales of portfolio companies, and served on the boards of many public and private companies. Through his experiences, he has gained valuable knowledge in the management, operations and finance of technology growth companies.
AGE: 67 DIRECTOR SINCE: 2000 COMMITTEES: NCGC |
| Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Other Public Company Boards |  |

15

Director Nominees
Jeanmarie F. Desmond
Independent Director

|  | From April 2019 to February 2020, Ms. Desmond was the Executive Vice President and Chief Financial Officer of DuPont de Nemours, Inc., a global multi-industry specialty solutions company (“DuPont”). Ms. Desmond previously served as Vice President and Co-Controller for DuPont from August 2017 to April 2019, and as finance leader for the Specialty Products division following the merger of DuPont with Dow Chemical. Ms. Desmond served in various leadership roles within DuPont in her 30-year career with the company. She also serves on the board and is treasurer of Delaware Prosperity Partnership, a public-private partnership overseeing economic development in Delaware. Since 2020, she has served on the board of Trinseo S.A., a materials solutions provider and a manufacturer of plastics, latex binders and synthetic rubber. In October 2021, she joined the board of Sylvamo Corporation, a global producer of uncoated paper. Ms. Desmond earned a B.S. in Accounting from Mt. St. Mary’s University and is a certified public accountant (inactive). KEY ATTRIBUTES, EXPERIENCE AND SKILLS Ms. Desmond brings to the Board substantial finance and accounting experience and extensive experience in technology-driven companies. Her long management experience in a number of key strategic areas including finance leadership and operations financial planning and analysis, tax, internal audit, accounting controls, risk management, mergers and acquisitions, investor relations and public-private partnership brings depth to the skillsets of the Board.
AGE: 55 DIRECTOR SINCE: 2021 COMMITTEES: Audit Committee DIRECTORSHIP AT OTHER PUBLIC COMPANY: Sylvamo Corporation and Trinseo S.A. |
| Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership | Other Public Company Boards | Non-Corporate Experience

16 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Director Nominees
Gregory P. Dougherty
Independent Director

|  | Mr. Dougherty served as Chief Executive Officer of Oclaro, Inc., a maker of optical components and modules for the long-haul, metro and data center markets, from June 2013 and has served as a director of Oclaro from April 2009, until its December 2018 acquisition. Prior to Oclaro, Mr. Dougherty served as a director of Avanex Corporation, a leading global provider of intelligent photonic solutions, from April 2005 to April 2009. Mr. Dougherty also served as a director of Picarro, Inc., a manufacturer of ultra-sensitive gas spectroscopy equipment using laser-based technology, from October 2002 to August 2013, and as its Interim Chief Executive Officer from January 2003 to April 2004. From February 2001 until September 2002, Mr. Dougherty was the Chief Operating Officer at JDS Uniphase Corporation (“JDS”), an optical technology company. Prior to JDS he was the Chief Operating Officer of SDL, Inc., a maker of laser diodes, from March 1997 to February 2001 when they were acquired by JDS. Mr. Dougherty serves on the boards of directors of Infinera Corporation, a provider of optical transport networking equipment, software and services to telecommunications service providers and others, since January 2019, Fabrinet, a provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to OEMs of complex products, since February 2019, and MaxLinear, Inc., a provider of radio frequency (RF), analog and mixed-signal integrated circuits, since March 2020. Mr. Dougherty earned a B.S. in optics from the University of Rochester. KEY ATTRIBUTES, EXPERIENCE AND SKILLS Mr. Dougherty contributes to the Board significant leadership, operations, sales, marketing and general management experience in optics and components for telecommunications and other applications. For over three decades, Mr. Dougherty has worked in the optical and components industry and can provide the Board with insight into the industry and conditions in which the Company operates. Having been recently a CEO at a publicly-held company and now serving as a member of the board of several optical and electronics companies, he is familiar with a large range of management, corporate and board responsibilities and brings valuable perspectives to the Board as an independent director.
AGE: 62 DIRECTOR SINCE: 2019 COMMITTEES: Audit Committee, Compensation Committee (Chair) DIRECTORSHIP AT OTHER PUBLIC COMPANY: Infinera Corporation, Fabrinet and MaxLinear, Inc. |
|  | Lasers and Technology | Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership | Other Public Company Boards

17

Director Nominees
Eric Meurice
Independent Director

|  | Mr. Meurice was President and Chief Executive Officer of ASML Holding NV, a provider of semiconductor manufacturing equipment and technology, from October 2004 to June 2013, and Chairman until March 2014. From 2001 to 2004, he was Executive Vice President of the Thomson Television Division of Thomson, SA, an electronics manufacturer. From 1995 to 2001, he served as head of Dell Computer’s Western, Eastern Europe and EMEA emerging market businesses. Before 1995, he gained significant technology experience at ITT Semiconductors and at Intel Corporation. Mr. Meurice serves on the boards of Umicore S.A., a recycling and materials company, since April 2015, Soitec S.A., a semiconductor materials manufacturer, since July 2018, and where he was appointed Chairman since March 2019, and Global Blue Group Holding AG, a leader in currency and value added tax processing, since September 2020. He previously served on the boards of Verigy Ltd., a manufacturer of semiconductor test equipment, ARM Holdings plc, a semiconductor intellectual property supplier, NXP Semiconductors N.V., a semiconductor company, and Meyer Burger Technology AG, a solar equipment vendor. Mr. Meurice earned a Master’s degree in Mechanics and Energy Generation at the Ecole Centrale de Paris, a Master’s degree in Economics from la Sorbonne University, Paris, and an M.B.A. from the Stanford University Graduate School of Business. KEY ATTRIBUTES, EXPERIENCE AND SKILLS Mr. Meurice has extensive skills and experience as a manager of several rapidly-growing, complex and global businesses in the capital equipment and electronics fields with several billions of dollars in revenues, most recently as former President and Chief Executive Officer of ASML Holding NV. He has experience managing a publicly-held company as well as experience on serving on several public company boards in the equipment and technology fields such as Soitec S.A., NXP Semiconductors N.V., Umicore S.A., Verigy Ltd. and ARM Holdings plc. Mr. Meurice also has a record of proven leadership as a strategic thinker, operator and marketer at the businesses he managed.
AGE: 65 DIRECTOR SINCE: 2014 COMMITTEES: NCGC (Chair), Compensation Committee DIRECTORSHIP AT OTHER PUBLIC COMPANY: Umicore S.A., Soitec S.A. and Global Blue Group Holding AG |
| Lasers and Technology | Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership | Other Public Company Boards

18 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Director Nominees
Natalia Pavlova
Director

|  | Ms. Pavlova has worked in a variety of roles at non-profit art institutions including the RISD Museum, Worcester Historical Museum and The Willard House and Clock Museum. She also served in sales and marketing roles at the Company previously. Ms. Pavlova holds a Qualification for Fine Art Critic and Historian of Art and Culture from the Russian State University for the Humanities, and an M.S. in Arts Administration from Boston University. She is the spouse of co-founder and Senior Vice President, Chief Scientist, Igor Samartsev. KEY ATTRIBUTES, EXPERIENCE AND SKILLS As a significant stockholder with family association to founders of the Company as well as having served as an employee of the Company in sales and marketing, Ms. Pavlova’s membership on the Board provides it with further engagement by individuals having a long-term perspective and strong economic ties with the Company. Among her specific attributes that qualify her to serve as a member of the Board, Ms. Pavlova possesses extensive knowledge of our history and culture. Ms. Pavlova strengthens the connection between the Company’s founding members and our Board, thereby assisting in the alignment of the Board with the interests of all IPG stockholders. Her experience working for nonprofit organizations adds different perspectives to the boardroom.
AGE: 43 DIRECTOR SINCE: 2021 COMMITTEES: None |
|  | Financial Literacy | Non-Corporate Experience |  |  |  |  |  |

19

Director Nominees
Thomas J. Seifert
Independent Director

|  | Mr. Seifert is Chief Financial Officer of Cloudflare, Inc., an internet performance and security provider, from June 2017 to the present. Since July 2020, he is a member of the board of First Derivatives plc, a publicly held company in Ireland, that is a global technology provider working with some of the world's largest finance, technology, automotive, manufacturing and energy institutions. Mr. Seifert was a member of the board of CompuGroup Medical SE, a publicly held company in Germany, which provides software to support medical and organization activities in medical offices and facilities, from February 2018 to June 2020. Mr. Seifert was the Executive Vice President and Chief Financial Officer of Symantec Corporation, a provider of security, backup and availability solutions, from March 2014 to December 2016. Mr. Seifert served as Executive Vice President and Chief Financial Officer of Brightstar Corporation, a wireless distribution and services company, from December 2012 to March 2014. He was Senior Vice President and Chief Financial Officer at Advanced Micro Devices Inc., a semiconductor company, from October 2009 to August 2012, and served as Interim Chief Executive Officer from January 2011 to September 2012. From October 2008 to August 2009, Mr. Seifert served as Chief Operating Officer and Chief Financial Officer of Qimonda AG, a German memory chip manufacturer, and as Chief Operating Officer from June 2004 to October 2008. He also held executive positions at Infineon AG, White Oak Semiconductor, including the position as Chief Executive Officer, and Altis Semiconductor. Mr. Seifert has a Bachelor’s degree and a Master’s degree in Business Administration from Friedrich Alexander University and a Master’s degree in Mathematics and Economics from Wayne State University. KEY ATTRIBUTES, EXPERIENCE AND SKILLS Mr. Seifert has extensive experience as both an operating executive and chief financial officer of large publicly-held international technology businesses, such as Symantec and Advanced Micro Devices. In these and other senior positions, he developed deep financial and accounting knowledge, as well as managerial leadership skills, in larger organizations. With his background in accounting, finance and management, Mr. Seifert brings broad skills and knowledge to the Board, the Audit Committee and the NCGC including internal controls, mergers and acquisitions, integrations and information technology security.
AGE: 58 DIRECTOR SINCE: 2014 COMMITTEES: Audit Committee (Chair) - Audit Committee Financial Expert, NCGC DIRECTORSHIP AT OTHER PUBLIC COMPANY: First Derivatives plc |
| Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership | Other Public Company Boards |

20 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Director Nominees
Felix Stukalin
SVP, Chief Operating Officer and Director

|  | Mr. Stukalin has served as our Senior Vice President, Chief Operating Officer since February 2022. From February 2013 until February 2022, he served as our Senior Vice President, North America Operations. From March 2009 until February 2013, he served as our Vice President, Devices. Prior to joining us, he was Vice President, Business Development of GSI Group Inc. from April 2002 to September 2008, and from March 2000 to April 2002 he was Vice President of Components and President of the Wave Precision divisions of GSI Lumonics, Mr. Stukalin holds a B.S. in Mechanical Engineering from the University of Rochester and he is a graduate of the Harvard Business School General Management Program. KEY ATTRIBUTES, EXPERIENCE AND SKILLS As a senior executive of the Company, Mr. Stukalin has developed extensive knowledge of the Company’s business. The leadership and operational expertise of Mr. Stukalin have contributed to introduction of new products and strategy, IPG increasing production, lowering manufacturing costs, managing risk and maintaining high margins compared to our industry peers. With his prior business development experience, technical knowledge and strategic contributions to IPG, he brings a valuable perspective to the Board. His long-term service as an executive officer of the Company provides the Board with a detailed understanding of the Company’s operations, sales and customers.
AGE: 60 DIRECTOR SINCE: 2022 COMMITTEES: None |
| Lasers and Technology | Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership |

21

Director Nominees
Agnes K. Tang
Independent Director

|  | Agnes K. Tang is a Founding Partner at Ducera Partners LLC, which offers strategic advisory, mergers and acquisitions, capital advisory, liability, management and restructuring advisory services. Prior to joining Ducera in 2015, Ms. Tang was a Managing Director in the New York Office of Perella Weinberg Partners from 2008 to 2015. Prior to joining Perella Weinberg, Ms. Tang was an investment banking professional at Houlihan Lokey, and a strategy consultant at The Oliver Wyman Group, a business division of Marsh & McLennan Companies. Ms. Tang received a Bachelor of Arts in Economics from Northwestern University and a Master of Business Administration from the Harvard Business School. KEY ATTRIBUTES, EXPERIENCE AND SKILLS Her experience working across a range of industry sectors and different size companies provides her with a broad perspective in how companies manage to maximize business opportunity potential. Specializing in situations with multi-dimensional complexities, Ms. Tang has more than twenty years of experience working to find creative solutions for companies at strategic crossroads. She brings to the Board a combination of strategy, operational and financial acumen and a commitment to partnership and collaboration.
AGE: 48 DIRECTOR SINCE: 2022 COMMITTEES: None |
| Financial Literacy | Global Business | Business Development and M&A | Risk Management |  |  |  |

The Board of Directors recommends that you vote FOR each director nominee named in this Proxy Statement.

22 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Board Refreshment and Composition

Board Succession Planning
Our Board’s succession planning focuses primarily on the composition of our Board and its committees, anticipated retirements, succession plans for committee members and chairs, our commitment to Board diversity and recruiting strategies for adding new directors. In its succession planning, the NCGC and our Board consider the results of our Board’s annual self-assessment, as well as other appropriate information, including the types of skills and experience desirable for future Board members and the needs of our Board and its committees at the time in light of the Company’s long-term strategy.
•Thoughtful, Deliberate Board Refreshment Process. The Board’s refreshment actions reflect a thoughtful and deliberate process that is informed by our Company’s strategic needs as well as the Board’s annual self-assessment and director nomination processes. Our refreshment resulted in adding five new directors over the last four years.
•Appropriately Balance Experience and Perspectives While Ensuring an Orderly Transition. Our Board takes care as part of its Board refreshment process to appropriately balance new perspectives and the experience of existing directors while undergoing an orderly tran sition of roles and responsibilities on the Board and its committees.
•Importance of Board Diversity. Our Board continues to focus on the importance of board diversity. Three of the four most recent additions to our Board are female. As described below, in 2020, our Board adopted a policy to ensure the Board's external candidate pool contains diverse candidates.

DIRECTOR TENURE AND RETIREMENT AGE POLICIES •No Term Limits. •Our Board recognizes the importance of periodic Board refreshment and maintaining an appropriate balance of tenure, experience and perspectives on the Board. •We believe it is desirable to maintain a mix of longer-tenured, experienced directors with institutional memory and understanding of our business and culture and newer directors with fresh perspectives. However, we do not impose director tenure limits. •The Board believes that directors should not have an expectation of being re-nominated annually and that the NCGC’s assessment is a key component of its director nomination process. •In connection with the Board’s annual self-assessment and director nomination processes, the Board considers upcoming retirements, the average tenure and overall mix of individual director tenures of the Board, the overall mix of the skills, knowledge, experience and diversity, each individual director’s performance and contributions to the work of the Board and its committees, the personal circumstances and other time commitments of directors, along with other factors the Board deems appropriate. •The Board believes that, as an alternative to term limits, non-management directors should submit their resignation from the Board upon attaining the age of 72 and on each subsequent anniversary. The Board then considers the needs and circumstances confronting the Board and, upon recommendation of the NCGC, determines whether to accept or decline the resignation. •Our Board’s age resignation policy is intended to facilitate our Board’s recruitment of new directors with appropriate skills, experience and backgrounds and provides for an orderly transition of leadership on our Board.

23

Board Refreshment and Composition
Board Nomination Process

1 |  | 2 |  | 3 |  | 4
EVALUATION OF BOARD COMPOSITION |  | IDENTIFICATION OF POOL OF CANDIDATES |  | MEETINGS WITH POTENTIAL CANDIDATES |  | RECOMMENDATION OF POTENTIAL DIRECTORS FOR APPROVAL
•The NCGC and the Board evaluate Board composition annually and identify skills, experience and capabilities desirable for new directors in light of the Company’s long-term strategy |  | •The NCGC identifies potential nominees through multiple sources, including third-party search firm and input from stakeholders |  | •Evaluation and assessment of candidate interest, minimum qualifications, conflicts, independence, background and other information •Members of the NCGC, other Board members and executives meet with qualified candidates |  | •NCGC recommends potential nominees to the Board for approval •Stockholders vote on nominees approved by Board at next annual meeting of stockholders

The NCGC’s evaluation process and criteria does not vary based upon whether a candidate is recommended by a stockholder. However, the procedural requirements set forth in our bylaws and the procedures described below in A dditional Information - 2022 Annual Meeting and Nominations must be met.
The composite skills of the Board members and the ability and willingness of individual Board members to complement each other and to rely on each other's knowledge and expertise should produce informed Board members who are not afraid to disagree and who can intelligently assess management's performance and evaluate our strategic direction. In considering whether to recommend any candidate for nomination to the Board, including candidates recommended by stockholders, the NCGC must be satisfied that the recommended nominee meets the following qualifications at a minimum:

Character and Integrity | Must be an individual of the highest character and integrity
Leadership Experience | Demonstrated excellence, leadership and significant experience in their field of endeavor
Financial Literacy and Commitment to Representing Stockholders | Ability to read and understand financial statement fundamentals and commitment to representing the long-term interests of the Company’s stockholders, while keeping in perspective the interests of the Company’s customers, employees and the public
Independence and Constructive Collegiality | Must have a demonstrated ability to think and act independently as well as the ability to work constructively in a collegial environment. Must satisfy independence criteria of the SEC and Nasdaq, where independence is desired
Age | A potential director (excluding any incumbent) cannot be aged less than 21 or greater than 72 years
Limit on Other Public Boards | Independent directors – 3 (or 4 with Board approval) CEO - 1

The NCGC believes that our Board should be composed of directors who, as a group, have the experience and skills that are collectively required to make informed Board decisions and provide effective Board oversight to allow the Board to fulfill its responsibilities. The NCGC considers experience in our industry or markets, international business and cultural experience, experience serving on the boards of public companies, experience acquiring companies and diversity to be favorable characteristics in evaluating recommended nominees. With over two-thirds of our sales and employees in locations outside of the U.S.A., it is important to have the appropriate experience and background coming from being born and operating in other countries. We interpret diversity broadly, including with respect to gender, age, race, national origin, geographic background as well as differences of professional experience, global experience, education, and other individual qualities and attributes. Regulatory requirements are also considered. The NCGC does not assign specific weights to particular criteria and no particular criterion is necessarily applicable to all prospective nominees. The Board recognizes that the diversity of its members is directly impacted by the diversity of the pool of potential director candidates. The Board has a written policy requiring the pool of external candidates from which the NCGC recommends nominees to include female and/or racially/ethnically diverse candidates. To implement this policy, third-party search firms hired by the NCGC are instructed to include in the pool qualified candidates who reflect diverse backgrounds, including diversity of gender and/or race/ethnicity. Additionally, in 2021, the Board amended Director Selection Process and Membership Guidelines to formalize its commitment to its diversity.
24 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Board Roles and Responsibilities

Role in Risk Management

BOARD OVERSIGHT OF RISK The Board recognizes that effectively monitoring and managing risk are essential to the successful execution of the Company’s strategy. The Board has oversight for risk management at IPG with a focus on the most significant risks facing the Company, including strategic, operational, financial and compliance risks. Upon recommendation of the NCGC, the Board allocates risk oversight responsibility among the full Board, the independent directors acting as a group and the three standing committees of the Board as described below. Throughout the year, the Board, the independent directors and the committees to which the Board has delegated responsibility dedicate a portion of their meetings to review and discuss specific risk topics in greater detail.
AUDIT COMMITTEE The Audit Committee oversees the policies, processes and risk relating to the financial statements, financial reporting processes, auditing, cybersecurity and compliance risks. The Audit Committee discusses with management the Company’s risk assessment and risk management practices and, when reviewing and approving the annual audit plan for the Company’s internal audit function, prioritizes audit focus areas based on their potential risk. | COMPENSATION COMMITTEE The Compensation Committee oversees risk associated with management resources, including executive retention and non-CEO succession planning. It reviews the Company’s executive compensation practices, their effectiveness at linking executive pay to performance and aligning the interests of our executives and our stockholders, without encouraging excessive risk taking. The Compensation Committee annually reviews management’s assessment of compensation risk. | THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEE The NCGC oversees risk related to the Company’s governance structure and processes, and risks arising from related person transactions. It reviews processes and risk related to Board succession planning, authority delegated to management and certain compliance risk.
FULL BOARD Our entire Board as a whole reviews risk management practices and a number of significant risks in the course of its reviews of corporate strategy, management reports and reports from outside experts and professional advisors.
INDEPENDENT DIRECTORS As a group, the independent directors oversee risks related to CEO succession planning.

The Board’s risk oversight process builds upon management’s risk assessment and mitigation processes, which include reviews of strategic and operational planning, compliance under the Company’s Code of Business Conduct and other policies, the Company’s integrity programs, health, safety and other compliance, financial reporting and controllership, human capital management; environment, society and governance matters, and information technology and cybersecurity programs. The Board's oversight role is independent from the Company’s day-to-day management, as seventy percent of the current directors are independent and therefore have no conflicts that might discourage critical review of the Company’s risks.
25

Board Roles and Responsibilities
Role in Environmental, Social and Governance ("ESG") Oversight
Key ESG matters, including environmental risks, climate change risks, and human capital risks such as diversity, equity and inclusion, and employee health and safety, could have an adverse impact on our company. In February 2022, the Board reviewed an enterprise-level ESG risk assessment to identify and understand specific risks within the ESG realm that could have a material impact on the Company. Specific ESG topics are overseen by the Board as a whole, or, in limited circumstances, by the Board committee generally responsible for the subject matter. The Board also supports and regularly inquires about progress in the Company’s reporting of ESG policies, metrics and related disclosures. During 2021, the Board approved policies that enhance the Company’s commitments to respect human rights and to transparency of political contributions.

|  | BOARD OF DIRECTORS |  |
|  | General oversight of ESG matters, with emphasis on directing the Company's strategy and setting its course for growth |  |
AUDIT COMMITTEE |  | COMPENSATION COMMITTEE |  | NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
Oversees risks related to financial processes and controls, disclosures, financial risks and ethics |  | Oversees strategies and policies related to succession planning and management development, as well as the Company’s labor practices |  | Recommends risk management allocation, including ESG matters, among Board and committees, Board composition and stakeholder engagement
|  | MANAGEMENT |  |
|  | Responsible for the day-to-day management and execution of the Company's strategies and course for growth, including those relating to ESG matters |  |

Role in Management Succession Planning
The Board is focused on ensuring that the Company has emergency and long-term succession plans in place for key senior executive positions. The entire Board annually reviews with the CEO the Company’s plan for succession for the position of the chief executive officer, including the appropriate individual or individuals who are candidates to succeed to this position. In the event of an unexpected departure of the CEO, an emergency succession plan allows for smooth transfer of responsibilities to an individual who may or may not be permanently tasked with the new role. This planning was evident in 2021 with the smooth transfer of CEO responsibilities from the former CEO, Dr. Gapontsev to Dr. Scherbakov in May, and from Dr. Gapontsev to Mr. Peeler as Chair in October upon the death of Dr. Gapontsev. The Compensation Committee, composed entirely of independent directors, annually reviews the Company’s plan for succession for other senior executive officers.
If the succession plan is triggered for any of these roles, the full Board would participate in the discussion and consideration of any action with a final decision to be made by the full Board. In the event of a senior executive’s departure, both internal and external candidates may be considered for permanent appointment to a given role.
26 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Board Roles and Responsibilities
Role in Ethics
All directors, officers and employees are required to abide by IPG’s Code of Business Conduct to ensure that our business is conducted in a consistently legal and ethical manner. These policies form the foundation of a comprehensive process that includes compliance with corporate policies and procedures and a Company-wide focus on uncompromising integrity in every aspect of our operations. Our Code of Business Conduct covers many topics, including antitrust and competition law, conflicts of interest, financial reporting, protection of confidential information, and compliance with all laws and regulations applicable to the conduct of our business. All of our directors and employees receive bi-annual training on our Code of Business Conduct, which can be found on the investor section of our website under "Governance Documents." If the Board grants any waivers from our Code of Business Conduct to any directors or executive officers, or if we amend our Code of Business Conduct, we will, if required, disclose these matters via updates on our website. Information on our website does not constitute part of this Proxy Statement.
Role in Stockholder Engagement
Accountability to our stockholders is an important component of the Company’s success. We recognize the value of building informed relationships with our investors that promote further transparency and accountability.
While proxy voting is one direct way to influence corporate behavior, proactive engagement with our investors can be effective and impactful. Investor views are continuously communicated to the Board and are instrumental in the development of our governance, compensation and other policies and inform our business strategy. The Board continues to seek investor input on a range of issues and practices in furtherance of enhancing long-term stockholder value.

| Publish Annual Report and Proxy Statement. Speak with investors about topics to be addressed at the annual meeting. |  |  |  |  | Review results of the annual meeting, governance trends, and regulatory developments. Board conducts annual self-assessment of its performance and effectiveness. |
| Outreach to investors regarding our policies and practices. Consider input from investors to enhance disclosures, governance practices and compensation programs. |  | Communicate investor feedback to the Board. Board uses self-assessment to develop and implement changes improving effectiveness. |

27

Board Structure

Board Leadership Structure
•Non-Executive Chair: John R. Peeler
•All three Board committees composed entirely of independent directors
•Independent directors meet in executive session at each of the Board's regular meetings and as needed outside of such meetings
There is no single board leadership structure that is optimal in all circumstances. The Board, with its diverse skills and experience, considers the most appropriate leadership structure for the Company in the context of the specific circumstances and challenges facing IPG. The directors come from a variety of organizational backgrounds with direct experiences in a wide range of leadership and management structures. The independent directors, who comprise seventy percent of our Board, challenge management and demonstrate the independence necessary for effective oversight. The NCGC, in consultation with the other independent directors, evaluates on an ongoing basis whether the Board’s leadership structure is appropriate to effectively address the evolving needs of our business and the long-term interests of our stockholders. The NCGC then makes recommendations to the Board concerning the Board’s leadership structure. The Board, in accordance with our By-Laws, elects a Chair from among the directors. The Board believes it is in the best interests of the Company and its stockholders for the Board to determine which director is best qualified to serve as Chair in light of the circumstances at the time, rather than based on a fixed policy. In the event that the Chair is not an independent director, our Corporate Governance Guidelines require that a Lead Independent Director be elected on an annual basis by a majority of the independent directors.
In May 2021, Dr. Eugene Scherbakov transitioned into the CEO role and Dr. Valentin Gapontsev, then Chair and CEO, transitioned to the Executive Chair role, with John Peeler continuing to serve as Lead Independent Director. Effective October 29, 2021, following the passing of Dr. Gapontsev, Mr. Peeler was appointed by the Board to serve as Non-Executive Chair.
The Board believes that it is currently in the best interests of our stockholders that the Chair role be held by Mr. Peeler, who is an independent director. This leadership structure allows Dr. Scherbakov to focus on executing our strategic imperatives in this time of transition following the passing of our founder and longtime CEO. Meanwhile, in his capacity as Non-Executive Chair, Mr. Peeler can focus on leading the Board, ensuring that it provides strong oversight of management and that all directors have access to the resources required to discharge their duties appropriately.
Director Independence
Seven of our ten director nominees are independent as defined by Nasdaq and SEC rules. A predominantly independent Board ensures that the Board is acting objectively and in the best interests of our stockholders. The independent directors also bring expertise and a diversity of perspectives to the Board. The culture of the Board enables directors to openly express their opinions in the boardroom and to raise challenges. Nasdaq listing standards governing independence require that a majority of the members of the Board be independent as defined by Nasdaq. Also, our Corporate Governance Guidelines require that a majority of the Board members be independent. In general, our Corporate Governance Guidelines also require that an independent director must have no material relationship with the Company, directly or indirectly, that might interfere with the exercise of independent judgment in the performance of director responsibilities.
The NCGC conducted its annual review of the independence of the directors (and candidates for membership on the Board) in March 2022, taking into account relevant facts and circumstances, and reported its findings to the full Board. The NCGC determines independence on the basis of the standards specified by Nasdaq, the additional standards referenced in our Corporate Governance Guidelines, and other facts and circumstances the Board considers relevant. During this review, the NCGC examined all direct and indirect transactions or relationships between the Company or any of its subsidiaries and each current independent director and any immediate family member of the independent director and dete rmined that no material relationships with the Company existed during 2021. On the basis of this review, the NCGC determined that each of the following director nominees qualifies as an independent director as defined in Nasdaq guidelines, SEC rules and under our Corporate Governance Guidelines: Michael C. Child, Jeanmarie F. Desmond, Gregory P. Dougherty, Eric Meurice, John R. Peeler, Thomas J. Seifert and Agnes Tang. Addition ally, the Board has determined that each member of the Audit Committee and the Compensation Committee meets the independence standards specific for members of such committees under Nasdaq guidelines and SEC rules. Ms. Pavlova is not considered independent because she is the spouse of Dr. Igor Samartsev, an executive officer of the Company. The Board determined that Dr. Eugene Scherbakov, our CEO and Felix
28 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Board Structure
Stukalin, our Senior Vice President and Chief Operating Officer, are not independent. Our former Executive Chair, Dr. Valentin Gapontsev, was not independent.
Executive Sessions. Our independent directors meet privately, without non-independent directors or management present, at least four times during the year. These private sessions are generally held in conjunction with the regular quarterly Board meetings. Other private meetings of the independent directors are held as often as deemed necessary by them and are led by the Mr. Peeler as non-executive Chair. The Audit Committee, the Compensation Committee and the NCGC meet without non-independent directors or management present from time to time as they deem necessary.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Messrs. Dougherty, Meurice and Peeler and Ms. Catherine P. Lego, who did not stand for re-election at the 2021 annual meeting, served as members of our Compensation Committee in 2021. None of these persons has at any time been an officer or employee of our Company or any of our subsidiaries. During fiscal year 2021, none of the Company’s executive officers served as a member of the board of directors or compensation committee of another entity in which one of the executive officers of such entity served as a member of the Company’s Board of Directors or Compensation Committee.
29

Standing Committees and Board Committee Membership

The Board has a standing Audit Committee, Compensation Committee and NCGC, each composed entirely of non-employee, independent directors. Under their written charters adopted by the Board, each of these committees is authorized and assured appropriate funding to retain and consult with external advisors, consultants and counsel. Below we provide the principal functions and current members of the standing Board committees.
Audit Committee

MEMBERS | FUNCTIONS:
Thomas J. Seifert (Chair) Jeanmarie F. Desmond Gregory P. Dougherty Meetings in 2021: 8 | •Providing oversight of financial management, the internal auditor function and the independent auditor. •Providing oversight with respect to our internal controls including that management is maintaining an adequate system of internal control such that there is reasonable assurance that assets, systems and processes are safeguarded and that financial reports and certain other datasets are properly prepared; that there is consistent application of generally accepted accounting principles; and that there is compliance with management’s financial reporting policies and procedures. •Pre-approving audit and permissible non-audit services by our independent auditor, reviewing and discussing our annual and quarterly financial statements and related disclosures. •Meeting periodically with the independent auditor, management and internal auditor function (including in private sessions) to review their work and confirm that they are properly discharging their respective responsibilities. •Appointing the independent auditor. For more information on Audit Committee activities in 2021, see the Audit Committee Report on page 63 of this Proxy Statement and Proposal 2: Ratify Deloitte & Touche LLP as Our Independent Registered Public Accounting Firm for 2022 on page 61.

The Board has determined that each member of the Audit Committee is independent and financially literate. The Board has designated Ms. Desmond and Mr. Seifert, who are each independent directors under the Nasdaq listing standings and the SEC's audit committee requirements, as “audit committee financial experts” pursuant to the SEC’s final rules implementing Section 407 of the Sarbanes-Oxley Act. Stockholders should understand that the designation of Ms. Desmond and Mr. Seifert each as an “audit committee financial expert” is an SEC disclosure requirement and that it does not impose upon them any duties, obligations or liabilities that are greater than those imposed on them as members of the Audit Committee and the Board in the absence of such designation.
30 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Standing Committees and Board Committee Membership
Compensation Committee

MEMBERS | FUNCTIONS:
Gregory P. Dougherty (Chair) Eric Meurice John R. Peeler Meetings in 2021: 10 | •Reviewing and recommending to the independent directors the CEO’s base salary and opportunities for annual and long-term compensation. •Reviewing and approving compensation recommendations by the CEO for the other executive officers, including base salaries, annual performance bonuses, long-term incentive awards, severance benefits, perquisites and employment agreements. •Setting our compensation philosophy and composition of the group of peer companies used for comparison of executive compensation. •Reviewing and recommending for approval by the Board the compensation for non-employee directors. •Administering the equity compensation plans under which we compensate our executive officers and other key employees. •Retaining an independent compensation consultant firm for matters related to executive officer and director compensation, and outside legal counsel to provide advice on compensation-related matters. •Preparing the Compensation Committee Report included in this Proxy Statement on page 39 and overseeing management’s risk assessment of compensation for all employees and compensation-related risks as delegated by the Board.

Nominating and Corporate Governance Committee

MEMBERS | FUNCTIONS:
Eric Meurice (Chair) Michael C. Child John R. Peeler Thomas J. Seifert Meetings in 2021: 6 | •Overseeing matters of corporate governance, including the evaluation of the performance and practices of the Board. •Developing and recommending criteria for Board membership. •Reviewing possible candidates for the Board and recommending director nominees to the Board for approval. •Overseeing the process for the performance evaluations of the Board and its committees. •Engaging in Board succession planning to ensure boardroom skills are aligned with IPG’s long-term strategic plan. •Reviewing and recommending director orientation, stock ownership guidelines, delegation of authority to management, insider trading guidelines, and consider questions of possible conflict of interest, including related party transactions, as such questions arise. •Reviewing and recommending risk oversight responsibilities, including ESG matters, of the Board and its committees and of the independent directors as a group.

Each of the Board committees has a written charter that states their respective purposes, goals and responsibilities as well as qualifications for committee membership, appointment and removal, committee structure and operations and reporting to the entire Board. The three committee charters and our Corporate Governance Guidelines can be found on the investor section of our website under "Governance Documents." Information on our website does not constitute part of this Proxy Statement.
31

Board Practices, Policies and Processes

Director Meetings and Policy Regarding Board Attendance
It has been the practice of our Board and its committees to hold at least four in-person quarterly meetings each year preceding the announcement of our quarterly results and to also conduct telephone meetings throughout the year. In light of the ongoing COVID-19 pandemic, however, the Board conducted quarterly meetings by videoconference from April 2020 - July 2021. Our directors are expected to spend the time needed to prepare for and participate in each meeting and to meet as frequently as necessary to properly discharge their responsibilities. We encourage members of our Board to attend annual meetings of stockholders, but we do not have a formal policy requiring them to do so. In 2021, six of the directors in office attended the annual meeting of stockholders by teleconference.
32 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Board Practices, Policies and Processes
The table below sets forth the number of meetings held by each committee and the full Board in 2021. All incumbent directors attended 75% or more of the aggregate meetings of the Board and committees on which they served during 2021.

| Board of Directors | Audit | Compensation | Nominating and Corporate Governance
Meetings held in 2021 | 5 | 8 | 10 | 6
Written consents in 2021 | 5 | 0 | 1 | 0

Corporate Governance Guidelines
Our Board adopted Corporate Governance Guidelines that outline, among other matters, the roles and functions of the Board, the responsibilities of various Board committees and the mission of the Board. Our Corporate Governance Guidelines can be found on the investor section of our website under "Governance Documents." Information on our website does not constitute part of this Proxy Statement.
The Corporate Governance Guidelines provide, among other things, that:
•a majority of our Board must be independent
•the non-executive Chair or Lead Independent Director, as applicable, presides over executive sessions of independent directors
•the Board appoints all members and chairpersons of the Board committees, including filling of vacancies, after the NCGC recommends appropriate candidates
•the Audit Committee, Compensation Committee, and NCGC consist solely of independent directors
•the independent directors meet at least quarterly in executive sessions without the non-independent directors or management
•independent directors may not serve on the boards of more than three other public companies or, with the permission of the Board, four; the CEO may not serve on more than one other public company board
•the Board and Compensation Committee annually reviews the succession plans of the CEO and senior management
•directors cannot disclose confidential information to any person or entity outside of the Company or use such information for personal benefit
•Board self-assessments are conducted annually and committee self-assessments bi-annually and
•Board members are subject to a stock ownership policy (described below) to ensure that they have a meaningful financial stake in the Company.
The Board monitors changing legal and regulatory requirements, evolving best practices and other developments. The Board modifies the Corporate Governance Guidelines and its other corporate governance policies and practices from time to time, as appropriate.
Director Orientation and Continuing Education
The Board and its committees proactively monitor legislative and regulatory initiatives, as well as other corporate governance trends and their potential impact on the Company. The Board receives presentations from professionals with expertise in corporate law, governance and other related topics. These experts have specialized knowledge of regulatory actions, govern ance trends, various other corporate governance topics and technical matters. In 2021, the Board and its committees received presentations on board oversight and stockholder engagement, environment, social and governance topics, critical accounting matter disclosures and cybersecurity. Additionally, our directors engage in continuing education to remain informed on recent trends applicable to their committee du ties.
Likewise, newly elected directors attend a comprehensive director orientation program that covers, among other things, our strategy, business structure, manufacturing operations, sales, target markets and applications, financial performance, risks and competitive landscape. New committee members are also provided training on committee policies, practices and trends. As part of this program, directors are asked to tour facilities as appropriate. To further familiarize directors with our expanding operations, we conduct Board meetings at our major manufacturing facilities from time to time.
33

Board Practices, Policies and Processes
Board Performance Evaluations
The Board conducts annual self-assessments and its committees conduct bi-annual self-assessments to determine whether they are functioning effectively. Further, the performance of the Lead Independent Director is evaluated annually. The NCGC oversees the Board and committee self-assessments. Each committee also reviews its own performance bi-annually and reports the results to the Board. Each committee reviews and reassesses the adequacy of its charter annually and recommends proposed changes to the Board.
Prohibition on Hedging; Limits on Pledging
Under our insider trading policy, no director or employee, including NEOs, may engage in shorting shares of our common stock; buying or selling puts, calls or derivatives related to our common stock or other Company securities, which includes equity compensation; or engaging in hedging transactions, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds. No director or officer, including NEOs, may pledge shares constituting more than 20% of his or her total stock ownership. Pledges of shares constituting 20% or less of total stock ownership are subject to certain conditions.
Communication with our Board of Directors
Interested parties wishing to write to the Board, a specified director or a committee of the Board should send correspondence to the Office of the Secretary, IPG Photonics Corporation, 50 Old Webster Road, Oxford, Massachusetts 01540. All written communications received in such manner from stockholders of the Company will be forwarded to the members or committee of the Board to whom the communication is directed or, if the communication is not directed to any particular member(s) or committee(s) of the Board, the communication will be forwarded to all members of the Board.
Procedures for Submitting Complaints
We have procedures to treat complaints regarding accounting, internal accounting controls, auditing matters, fight against bribery, banking, and financial crime, including submission of confidential and anonymous concerns regarding questionable accounting, internal accounting controls or auditing matters raised by our directors, officers and employees. These procedures can be found on the investor section of our website under "Governance Documents." Information on our website does not constitute part of this Proxy Statement.
Transactions with Related Parties
The Board adopted a written related person transaction policy that requires the NCGC to approve or ratify any transaction or series of transactions exceeding $120,000 in which our Company is a participant and any related person has a direct or indirect material interest (other than solely as a result of being a director or trustee or less than 10% owner of another entity) ("Related Party Transactions"). Related persons include our directors, director nominees and officers and their immediate family members and persons sharing their households. It also includes persons controlling more than 5% of our outstanding common stock. Subject to certain exceptions in the policy, related parties are required to notify the NCGC of the Related Party Transaction for an assessment of whether the transaction or proposed transaction should be permitted. Management also has established procedures for monitoring transactions that could be subject to approval or ratification under the Related Party Transactions policy.
In deciding whether to approve or ratify the Related Party Transaction, the NCGC considers relevant facts and circumstances. The committee takes into account, among other factors, whether the transaction is on terms no more favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related person’s interest in the transaction. Once a Related Party Transaction has been identified, the NCGC reviews all of the relevant facts and circumstances and approves or disapproves entry into the transaction. Members of the NCGC having an interest in a transaction excuse themselves for the consideration and approval of the transaction in which they have an interest. Certain transactions are exempt from the policy including compensation paid by the Company for service as a director or an officer.
Pursuant to our Corporate Governance Guidelines, we expect each of our directors to ensure that other existing and future commitments do not conflict with or materially interfere with his or her service as a director. In addition, directors are required to inform the chairman of our NCGC and the Chairman of the Board prior to joining the board of another public company to ensure that any potential conflicts, excessive time demands or other issues are carefully considered.
The NCGC reviewed and approved the following Related Party Transactions for 2021 in compliance with our policy:
Dr. Gapontsev leased the annual right to use 25% of the Company’s corporate aircraft under a July 2017 lease agreement (the “Aircraft Lease”). The Aircraft Lease expires in July 2022. The annual lease rate is $924,700 and future rent payments are adjusted annually. The Company invoiced Dr. Gapontsev $924,280 in 2021 for use of the aircraft. Dr. Gapontsev directly paid
34 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

an unrelated flight management firm for the operating costs of his private use of the aircraft, including pilot fees, fuel and other costs.
From time to time, certain institutional investors may become beneficial owners of 5% or more of the voting securities of the Company and, as a result, are considered a related person under the policy. These organizations may provide services to the Company or its benefit plans. In 2021, participants in our 401(k) Retirement Plan paid approximately $167,410 in fees to affiliates of The Vanguard Group representing expense ratios associated with the Vanguard investment funds in the 401(k) Retirement Plan.

Director Compensation

Our non-employee directors receive the following annual compensation from us:

| Amount
Board Retainer | $ | 40,000 |
Non-Executive Chair Retainer (if applicable) | $ | 70,000 |
Lead Independent Director Retainer (if applicable) | $ | 40,000 |
Audit Committee Retainers |
Chair | $ | 25,000 |
Non-Chair | $ | 12,500 |
Compensation Committee Retainers |
Chair | $ | 22,500 |
Non-Chair | $ | 10,000 |
NCGC Retainers |
Chair | $ | 17,500 |
Non-Chair | $ | 7,500 |
Annual Equity Award | $ | 250,000 |

Following our annual meeting of stockholders in 2021, non-employee directors received an equity award of service-based restricted stock units ("RSUs") with a value of approximately $250,000. The annual awards vest in a single installment on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders.
Upon election to the Board, each new non-employee director receives a grant of approximately $250,000 in RSUs vesting on the first anniversary of the date of grant subject to the director’s continued service on the Board. If the election to the Board for a new director occurs other than at an annual meeting of stockholders, the subsequent annual equity grant is pro-rated based upon time the director served since first election.
Any director who retires after at least eight years of service on the Board will be entitled to full vesting of all RSUs then held by the director.
35

Director Compensation
Director Compensation Table
The following table summarizes the compensation of each of our non-employee directors for 2021:

Name | Fees Earned or Paid in Cash ($) | Stock Awards ($)(1) | Total ($)
Michael C. Child | 47,500 | 249,940 | 297,440
Jeanmarie F. Desmond(2) | 55,887 | 374,417 | 430,304
Gregory P. Dougherty | 71,563 | 249,940 | 321,503
Catherine P. Lego(3) | 21,387 | 0 | 21,387
Eric Meurice | 67,500 | 249,940 | 317,440
Natalia Pavlova(2) | 42,581 | 374,417 | 416,998
John R. Peeler | 97,910 | 249,940 | 347,850
Thomas J. Seifert | 72,500 | 249,940 | 322,440

(1)Valuation based on the fair value of the RSU awards as of the grant date determined pursuant to Financial Accounting Standards Board Accounting Standards Codification Topic 718 ("ASC Topic 718") with respect to 2021. The assumptions that we used with respect to the valuation of RSU awards are set forth in Note 15 to our Consolidated Financial Statements in our Annual Report. On February 19, 2021, in connection with their appointment to the Board, Mses. Desmond and Pavlova were each granted 1,065 RSUs, which vested in a single installment on February 19, 2022. On May 25, 2021, each continuing director serving on the Board was granted 1,201 RSUs, which will vest in a single installment on May 25, 2022, except that Mses. Desmond and Pavlova each received a pro-rated grant of 600 RSUs.
(2)Mses. Desmond and Pavlova joined the Board on January 7, 2021.
(3)Ms. Lego did not stand for re-election at the 2021 annual meeting and ceased to be a director on May 25, 2021.
Outstanding Equity Awards Table
The following table provides information regarding unexercised stock options and unvested RSUs held by each of our non-employee directors on December 31, 2021:

Name | Unvested Restricted Stock Units (#) | Total Option Awards Held (#)
Michael C. Child | 1,201 | 17,078
Jeanmarie F. Desmond | 1,665 | 0
Gregory P. Dougherty | 1,201 | 3,259
Eric Meurice | 1,201 | 20,001
Natalia Pavlova | 1,665 | 0
John R. Peeler | 1,201 | 7,576
Thomas J. Seifert | 1,201 | 1,113

The Company no longer grants stock options to non-employee directors. All previously-granted options were vested as of December 31, 2021.
Our certificate of incorporation limits the dollar amount of personal liability of our directors for breaches by them of their fiduciary duties. Our certificate of incorporation requires us to indemnify our directors to the fullest extent permitted by the Delaware General Corporation Law. We have also entered into indemnification agreements with all of our directors and we have purchased directors’ and officers’ liability insurance.
36 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Director Compensation
Objectives of Director Compensation
Quality non-employee directors are critical to our success. We believe that the two primary duties of non-employee directors are to effectively represent the long-term interests of our stockholders and to provide guidance to management. As such, our compensation program for non-employee directors is designed to meet several key objectives:
•Adequately compensate directors for their responsibilities and time commitments and for the personal liabilities and risks that they face as directors of a public company.
•Attract the highest caliber non-employee directors by offering a compensation program consistent with those at companies of similar size, complexity and business character.
•Align the interests of directors with our stockholders by providing a significant portion of compensation in equity and requiring directors to own our stock.
•Provide director compensation that is simple and transparent to stockholders and reflects corporate governance best practices.
We also believe in aligning director compensation with stockholder interests. In 2021, approximately 81% of our non-employee director compensation was at-risk by being subject to stock price performance.
Elements of Director Compensation
We believe that the following components of our director compensation program support the objectives above:
•We provide cash compensation through retainers for Board and committee service, as well as additional cash retainers to the non-executive Chair of the Board and chairs of our standing Board committees. We do not provide Board and committee meeting fees. Compensating our directors in this manner simplifies the administration of our program and creates greater equality in rewarding service on committees of the Board. The additional retainers compensate directors for the additional responsibilities and time commitments involved with chairperson responsibilities.
•We pay for, provide or reimburse directors for expenses, including business class travel, incurred to attend Board and committee meetings and director education programs. We do not pay our non-employee directors any additional payments or perquisites.
•Directors do not have a retirement plan.
•Directors who are also employees receive no additional compensation for service on the Board.
37

Director Compensation
Determining Director Compensation
Our Compensation Committee reviews our director compensation program every other year to confirm that the program remains appropriate and competitive and recommends any changes to our full Board for consideration and approval.
In 2021, the Compensation Committee engaged Aon to provide a comprehensive review of compensation for non-employee directors in comparison to the same compensation peer group used for the Company’s executive compensation analysis. The analysis included review of cash retainers, initial and annual equity grants, vesting schedules, and meeting fees for Board and committee service. Based upon its review, the Compensation Committee determined that the director compensation continues to be appropriate, but recommended, and the Board approved, an increase of $10,000 in the annual retainer for the Lead Independent Director in early 2021 in consideration of the demands of the position. Effective October 31, 2021, following the appointment of Mr. Peeler as non-executive Chair of the Board, the Compensation Committee recommended, and the Board approved, an annual retainer of $70,000 for the newly created position of non-executive Chair of the Board. With the appointment of Mr. Peeler to non-executive Chair, the Board does not presently have a Lead Independent Director.
DETERMINING NON-EMPLOYEE DIRECTOR COMPENSATION

1 |  | 2 |  | 3
The Compensation Committee engages independent compensation consultant to review compensation of non-employee directors as compared to peer group. |  | The Compensation Committee evaluates independent compensation consultant report, compensation trends and need to retain and attract high caliber non-employee directors consistent with comparable companies. |  | The Board considers changes to non-employee directors compensation program recommended by the Compensation Committee.

Director and Executive Officer Stock Ownership Guidelines
The Board adopted stock ownership guidelines to more closely align the interests of our directors and executive officers with those of our long-term stockholders. Under the guidelines, the following persons are expected to maintain a minimum investment in our common stock as follows:
•Non-employee directors, five times their annual cash Board retainers (excluding committee retainers);
•The CEO, five times his annual salary; and
•Senior executive officers, two times their respective annual salaries.
Unvested RSUs count toward required stock ownership levels; stock options (whether vested or unvested) and unvested PSUs do not. Indirect ownership of shares through a separate legal entity counts toward fulfillment of the ownership guidelines. Ownership requirements are to be achieved no later than four years after the election as a director or being appointed as an executive officer, except that prior to such time the director or officer is expected to retain a certain portion of stock issued upon exercise of stock options or vesting of RSUs and PSUs until the minimum ownership levels are attained. All directors and executive officers were in compliance with our stock ownership guidelines as of December 31, 2021.
38 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Compensation Committee Report

The Compensation Committee of the Board has reviewed and discussed with management the Compensation Discussion and Analysis included in this Proxy Statement. Based on this review and discussion, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in the Company’s Proxy Statement for the Company’s 2022 Annual Meeting of Stockholders and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
COMPENSATION COMMITTEE
Gregory P. Dougherty, Chair
Eric Meurice
John R. Peeler
March 16, 2022
The information in the Compensation Committee Report shall not be considered “soliciting material” or “filed” with the SEC, nor shall this information be incorporated by reference into any previous or future filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company incorporates it by specific reference.
39

Compensation Discussion and Analysis

Executive Overview
This Compensation Discussion and Analysis provides a review of our executive compensation philosophy and program, and Compensation Committee decisions for fiscal 2021. The discussion in this section focuses on the compensation of the NEOs for fiscal 2021, who were:

EUGENE SCHERBAKOV, PH.D. | Chief Executive Officer
TIMOTHY P.V. MAMMEN | Senior Vice President and Chief Financial Officer
ANGELO P. LOPRESTI | Senior Vice President, General Counsel and Secretary
ALEXANDER OVTCHINNIKOV, PH.D. | Senior Vice President, Chief Technology Officer
FELIX STUKALIN | Senior Vice President, Chief Operating Officer
VALENTIN P. GAPONTSEV, PH.D. (1) | Former Chief Executive Officer and Executive Chair

(1) On May 4, 2021, Dr. Gapontsev transitioned from CEO to the role of Executive Chair. Dr. Gapontsev passed away on October 22, 2021.
Detailed bios of the current NEOs are included in the Annual Report.
Financial and Strategic Highlights of 2021
IPG reported record annual revenue in 2021 despite the continued uncertainty in the global operating environment and increased competition. Net sales increased 22% year over year, driven by increased demand in Europe, North America and China. Materials processing revenue increased 22%, driven by higher demand in welding, marking, 3D printing and cleaning applications. Sales in other applications increased 15%, driven by growth in medical and advanced applications. We continued to focus on our strategy and successfully diversify our revenue into emerging growth applications. Our industry-leading gross margin increased from 45% in 2020 to approximately 48% in 2021 due to lower manufacturing costs as a percentage of sales and the absence of additional inventory charges. We delivered operating cash flow of $390 million in 2021 and have a strong balance sheet with cash, cash equivalents and short-term investments of $1.5 billion at December 31, 2021 and ample liquidity.
2021 Executive Compensation Highlights and Changes to 2022 Compensation Program
On May 4, 2021, the Company announced that Dr. Gapontsev transitioned to the role of Executive Chair and Dr. Eugene Scherbakov, the then Chief Operating Officer, Managing Director of IPG Laser GmbH, Senior Vice President, Europe and Director, succeeded Dr. Gapontsev as the Company’s Chief Executive Officer. Dr. Scherbakov's salary was increased to €724,900, and his annual incentive target (financial plus individual performance) under the Company’s Senior Executive Annual Incentive Plan increased to 110% of his base salary, with the financial performance minimum, target and maximum payout increasing to 20.75%, 83% and 221% of base salary, respectively, and the individual performance maximum payout increasing to 27.5% of base salary. In connection with his new role, the Company also granted $2,000,000 of long-term incentives to Dr. Scherbakov in the form of equity awards consisting of service-based restricted stock units (“RSUs”) weighted 50% and performance-based stock units (“PSUs”) weighted 50%. Both the RSUs and PSUs have the same performance criteria and performance periods as those granted to Dr. Scherbakov in February 2021. Additionally, the Company agreed to pay or reimburse Dr. Scherbakov on an after-tax basis for his expenses related to his employment in the United States, including relocation assistance, automobile, housing costs, health and disability insurance, tax preparation, repatriation and air transportation costs for him and his spouse.
In light of competitive analysis and peer salaries and having generally held executive base salaries at levels set in January 2018, the Compensation Committee approved increases of 7.5% and 5% to Dr. Gapontsev and Mr. Mammen, respectively, and of 3% to the other named executive officers.
Variable cash compensation opportunity is based upon annual net sales and profitability against threshold, target and maximum performance goals. The Committee set the 2021 metrics at a time of macroeconomic uncertainty related to the ongoing COVID-19 pandemic and the introduction of new vaccines. Despite moderated demand for cutting in China, as well as persistent uncertainty due to supply chain constraints on the Company and its customers, which presented challenges in the back half of the year, the Company experienced solid sales growth in Europe, North America and Japan. This resulted in a
40 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Compensation Discussion and Analysis
more balanced business by geography, and in 2021 the Company achieved the maximum financial performance payout under the AIP. Each NEO also earned full payouts with respect to the individual performance component of the AIP, as each NEO managed effectively through the COVID-19 pandemic and achieved strong financial results. The Committee also increased Dr. Gapontsev's annual incentive target in February 2021 from 110% to 125% of base salary while he was still CEO in light of his contributions and data on CEO compensation paid by peers.
In February 2021, the Compensation Committee approved grants of long-term incentives in the form of equity awards for the NEOs other than Dr. Gapontsev. Grants remained at 2020 levels as a percentage of salary. The Compensation Committee approved 2021 awards of PSUs based upon relative total stockholder return (at target, 25%) and the ratio of operating cash flow to adjusted net income (at target, 25%), and service-based RSUs (50%).
For 2022, the Compensation Committee considered peer data showing rising compensation levels and approved a 3% increase to executive base salaries. Annual and long-term incentive levels remained the same as 2021, except that the Compensation Committee changed the performance metrics for PSUs to organic revenue growth and operating margin. The Committee chose these two measures because they are generally accepted as two fundamental drivers of sustained stockholder value and provide clearer line-of-sight measurements than many alternative measures. The Compensation Committee approved 2022 awards comprised of service-based RSUs (50%), and PSUs based upon organic revenue growth (at target, 25%), and operating margin (at target, 25%).

Stockholder Feedback |  |
At our 2020 annual meeting of stockholders, our stockholders overwhelmingly approved our executive compensation structure in a “say-on-pay” advisory vote, with over 95% voting in favor of our executive compensation structure. After considering the results of the 2020 vote, the Compensation Committee determined not to change its pay philosophy or practices. At our annual meeting in 2017, our stockholders approved an advisory "say-on-frequency" proposal to hold “say-on-pay” advisory votes every three years and, therefore, we elected to submit the advisory “say-on-pay” proposal to our stockholders on a triennial basis. The next "say-on-pay" advisory vote will be in 2023, at which meeting we will also hold another advisory "say-on-frequency" vote. |  | Say-on-pay approval during last stockholder vote (2020)

41

Compensation Discussion and Analysis
Stockholder-Minded Compensation Practices

PRACTICES WE EMPLOY |  | PRACTICES WE AVOID
ü Align our NEO Pay with Performance: Strong links of compensation to Company performance and stockholder returns for annual and long-term incentives. Annual bonus tied to revenue and net income and long-term incentives include performance-based stock units. ü Balance Annual and Long-Term Incentives: Incentive programs provide an appropriate balance of annual and long-term incentives and include multiple measures of performance. ü Use Long-Term Incentives to Link Executive Pay to Company Performance: Over half of NEO pay consists of long-term incentives. ü Cap Incentive Award Payouts: Annual incentive plan award payouts and certain long-term incentive awards are capped. ü Maximize Stockholder Value While Mitigating Risk: Service-based equity awards vest over four years. This incentivizes long-term growth and discourages short-term risk taking. ü Independent Compensation Consultant: The Compensation Committee retains a compensation consultant, who is independent and without conflicts of interest with the Company. ü Robust Stock Ownership Requirements: Officers and directors are subject to stock ownership guidelines to further align their interests with stockholder interests. Our NEOs substantially exceed the ownership guidelines. ü Clawbacks on Executive Compensation: We maintain a compensation recovery policy covering cash and equity. |  | û No Guaranteed Annual Bonuses: Our annual incentive compensation plan is performance-based and does not include any minimum payout levels. û No SERP or Pension: We have no supplemental executive retirement plans (SERPs) or defined benefit pension plans. û No Excise Tax Gross-Ups: We do not provide excise tax gross reimbursements for change in control payouts. û No Excessive Perquisites: We provide limited perquisites to our NEOs. û Hedging of Company Stock is Prohibited. û No Severance For “Cause” Terminations. û No Single-Trigger Change in Control Provisions. Equity awards for NEOs generally require a “double-trigger” of both a change-in-control and termination of employment for both cash and equity compensation acceleration. û No Stock Option Repricing without Stockholder Approval. Our equity plans prohibit repricing underwater stock options. û Pledging of Company stock is limited.

42 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

2021 Compensation of Named Executive Officers

Our Business and Our Compensation Philosophy
The guiding principles of our executive compensation philosophy and practices continue to be pay-for-performance, accountability for annual and long-term performance, alignment to stockholders’ interests and providing competitive pay to attract and retain executives. We believe our compensation program strikes the appropriate balance between utilizing responsible, measured pay practices and effectively incentivizing our executives to dedicate themselves fully to value creation for our stockholders.
Our executive compensation program is designed to focus our executive officers on both annual and long-term financial and operational performance without encouraging unnecessary risk. Approximately 84% of the average total direct compensation of our current NEOs in 2021 was at risk.
The PSU awards in the chart below are presented at target based upon grant date fair value. The annual incentive plan amounts are presented based on actual amounts earned under the annual incentive plan for services rendered in 2021, except for our CEO, Dr. Scherbakov, which show the amount he would have been entitled to had he served as CEO for the entire year. NEO figures below exclude the late Dr. Gapontsev, who did not receive equity grants due to his significant ownership of Company stock.

| Primary Compensation Elements | Objective
| Base Salary | •Provide a competitive fixed component of cash compensation to attract and retain talented and experienced executives with the knowledge and skills necessary to achieve the Company’s strategic business objectives •The Compensation Committee uses the services of an independent compensation consultant to assess the base salaries as compared to a competitive target range of the Company’s peer group •The Compensation Committee considers these factors when setting base salaries of the NEOs: scope of the NEO's responsibilities, contributions, skills, knowledge, experience, seniority and annual and long-term Company performance
CEO | OTHER NEOs
| Annual Incentive Plan | •Offer a variable cash compensation opportunity that may be earned based upon the level of achievement of challenging corporate goals, with an additional compensation opportunity based upon individual performance •Foster a shared commitment among executives through establishment of uniform Company financial goals •Award payouts are subject to a cap of 225% of target in a performance period
CEO | OTHER NEOs
Long-Term Incentives | •Align interests of our NEOs and stockholders by motivating executive officers to increase long-term stockholder value •Service-based equity awards consist of RSUs. They offer long-term retention while providing alignment with stockholder value creation •PSUs provide an additional incentive to our NEOs based on performance. 50% (at target) of PSUs are based on the Company's total stockholder return relative to a stock market index of companies in similar industries and 50% (at target) are based upon the ratio of operating cash flow to adjusted net income, measuring the Company's performance over three years •Enhance retention with vesting over four years for RSUs and three years for PSUs
CEO | OTHER NEOS
Performance-based Equity Award (PSUs) & Service-based Equity Award (RSUs)

43

2021 Compensation of Named Executive Officers
Base Salary
We provide base salary to our NEOs and other employees to compensate them for services rendered on a day-to-day basis during the fiscal year. Unlike annual cash incentives and long-term equity incentives, base salary is not subject to performance risk. The Compensation Committee reviews data provided by its independent compensation consultant and considers the factors when setting base salaries of the NEOs: experience, skills, seniority, knowledge and responsibilities of the executive and the individual’s performance assessment provided by the CEO. With respect to the CEO, the Compensation Committee additionally considers the performance of the Company as a whole in its recommendation to the independent directors, who set CEO compensation.
In February 2021, the Compensation Committee evaluated the base salaries and total cash compensation for the NEOs with the assistance of Aon, its independent compensation consultant. Having generally held executive base salaries at levels set in January 2018, the Compensation Committee approved increasing base salaries for NEOs by 3% from 2020 levels except for Dr. Gapontsev and Mr. Mammen, whose base salaries increased by 7.5% and 5% from 2020 levels, respectively. Additionally, in May 2021, in connection with Dr. Scherbakov's appointment as CEO and Dr. Gapontsev's transition to the role of Executive Chair, the Compensation Committee approved a base salary of €724,900 for Dr. Scherbakov.
2022 Update. The Compensation Committee approved merit increases in 2022 of 3% to the base salaries of our NEOs from 2021 levels following an assessment of base salaries and total cash compensation with the analysis of Aon.
Annual Incentives
To focus each NEO on the importance of the Company’s performance, a significant portion of the individual’s potential short-term compensation is in the form of annual cash incentive pay that is tied to the achievement of goals set by the Compensation Committee. Our NEOs participate in our Senior Executive Annual Incentive Plan (the “AIP”) administered by the Compensation Committee. The Compensation Committee determines who is eligible to receive awards under the AIP, defines performance goals and objectives for executives, establishes target awards for each participant for the relevant performance period, and determines the percentage of the target award that should be allocated to the achievement of each of the chosen performance goals in consultation with the CEO with respect to other executives.
Under the AIP, if a performance goal is met at the target level as determined by the Compensation Committee, the target bonus is paid for that goal. Performance above target results in a payout of a higher percentage of salary, up to 200% of the NEO’s target cash bonus for the financial performance targets. Performance below target results in a lower bonus payout for that goal if a minimum threshold is met, with 18.75% of the NEO’s target cash bonus as the minimum in such circumstance, or no payout if the minimum threshold is not met. At target, the financial performance payout accounts for 75% of the overall target award. The CEO can earn up to 25% of his target award based upon goals and objectives determined by the independent directors. For 2021, these goals and objectives included developing a growth strategy, optimizing current talent and adding to talent from inside the Company and outside. The other NEOs also are eligible for payouts up to 25% of the target award based on their individual performance and other factors the Compensation Committee deems relevant.
44 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

2021 Compensation of Named Executive Officers
ILLUSTRATION OF IPG’S ANNUAL INCENTIVE PLAN (AIP)
(1)Non-GAAP “Adjusted EBIT” is an internally defined performance measure that is derived from GAAP net income by adding back the provision for income taxes, interest expense and stock-based compensation expenses, deducting interest income and excluding foreign currency transaction gains and losses.
In February 2021, the Compensation Committee approved annual performance targets and targeted incentive payouts for the Company’s NEOs and other executive officers for fiscal year 2021 under the AIP. Consistent with prior years, the Compensation Committee identified two financial performance measures: net sales and adjusted EBIT, each as determined under the AIP, and assigned a 50% weighting factor to each financial performance goal. The Compensation Committee chose to focus on revenue and pretax profits so that our NEOs and other executive officers would be incentivized to deliver the types of financial performance that benefit our stockholders, namely sales and profits.
When the Compensation Committee set goals for management in February 2021, it was a time of macroeconomic uncertainty related to the ongoing COVID-19 pandemic and the introduction of vaccines. As the year progressed, the Company saw strong sales for its core high power fiber lasers used in cutting and welding applications as well as for newer emerging products in medical applications, electric vehicle battery production and solar cell manufacturing. Moderated demand for cutting in China, as well as persistent uncertainty due to supply chain constraints on the Company and its customers, presented challenges in the back half of the year, but sales growth in Europe, North America and Japan resulted in a more balanced business by geography. Increased price competition continued to adversely affect revenues and earnings.
The graphic below illustrates performance relative to the full-year goals that were set in February 2021.
2021 AIP FINANCIAL PERFORMANCE TARGETS AND RESULTS
($ in millions)

| Threshold 18.75% Payout |  | Target 100% Payout |  | Maximum 200% Payout | Component Weighing (%) | Financial Performance Award Earned (% of Target)
Revenue |  | 37.5 | 200%
Adjusted EBIT |  | 37.5 | 200%

Revenue in 2021 was a record $1,461 million, and adjusted EBIT in 2021 was $377 million. Revenue was achieved at 110% of target and adjusted EBIT was achieved at 114% of target despite the Compensation Committee determining to set targets
45

2021 Compensation of Named Executive Officers
approximately 10% and 23% above 2020 performance of revenue of $1,201 million and adjusted EBIT of $270 million, respectively. As a result, the NEOs earned the maximum financial performance payouts under the AIP.
Each NEO earned the full payouts with respect to the individual performance component as they managed effectively through the COVID-19 pandemic and CEO transition, generated growing sales despite supply chain disruptions to the Company and its customers, introduced new products and saw growing sales from recently introduced products, achieving greater diversity in our sales and more balance among geographic areas.
The table below shows, for each NEO, the total target annual incentive award, the threshold, target and maximum payouts with respect to financial performance, the maximum payout with respect to individual performance and actual bonus payout for 2021.
($ in thousands)

Named Executive Officer | Target as a % of Base Salary(1) | Target Award(1) | Financial Performance | Individual Performance Maximum | Actual Award
Threshold | Target | Maximum
Eugene A. Scherbakov(2) | 110% | $851 |  | $213 | $1,920
Timothy P.V. Mammen | 80% | $404 |  | $101 | $910
Angelo P. Lopresti | 80% | $364 |  | $91 | $820
Alexander Ovtchinnikov | 80% | $361 |  | $90 | $812
Felix Stukalin | 80% | $353 |  | $88 | $795
Valentin Gapontsev(3) | 125% | $1,250 |  | $313 | $2,273

(1)Target award includes both financial (weighted at 75%) and individual performance (weighted at 25%) targets. Maximum award from all performance elements limited to 225% of target.
(2)Dr. Scherbakov's target was increased from 100% to 110% of salary in connection with his appointment as CEO. Amounts listed above are with respect to his targets as CEO. The actual award amount reflects the sum of prorated amounts from service as allocated between the periods he was COO and CEO. Dr. Scherbakov's salary is in Euros; amounts listed were translated into U.S. Dollars at the average daily exchange rates for the full year.
(3)Dr. Gapontsev received a payout for 2021 prorated through his last day of employment.
For 2021, NEOs target bonus percentages remained the same as 2020 except Dr. Gapontsev's target was increased from 110% to 125% of base salary and Dr. Scherbakov's target was increased from 100% to 110% in connection with his appointment as CEO.
2022 Update. For 2022, annual incentive payouts targets as a percentage of salary remained the same as 2021. The performance measures remained the same but with different targets, thresholds and maximums.
46 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

2021 Compensation of Named Executive Officers
Long-Term Incentives
The goal of our equity-based award program is to provide employees and executives with the perspective of an owner with a long-term financial stake in our success, further increasing alignment with stockholders. Our equity-based incentives align the interests of our executives and stockholders by motivating executives to increase long-term stockholder value.
In 2021, our equity-based award program for our NEOs (other than Dr. Gapontsev) included RSUs and PSUs, with each award type representing half of the overall 2021 long-term incentive award opportunity (at target for the PSUs). The type and proportion of the equity grants reflected a 2021 review by our Compensation Committee with the assistance of Aon of equity award practices at peer companies. The Committee believes that granting a balance of RSUs and PSUs appropriately aligns executive compensation with the achievement of the Company’s strategic goals and long-term stockholder value creation. Additionally, the value of the RSUs and PSUs are tied to the Company's stock price which further links pay to performance.

2021 EQUITY ELEMENTS

Consistent with prior year long-term incentive awards, in February 2021, the Compensation Committee determined to weight 50% of the PSU value on relative total stockholder return and 50% on the ratio of operating cash flow to adjusted net income. For the PSUs based upon relative total stockholder return ("TSR PSU"), the performance of the Company’s stock is measured against the S&P Composite 1500 Electronic Equipment, Instrument and Components Index, an index the Company has used for benchmarking since 2019. For each 1% that IPG’s common stock exceeds the performance of such index for the trailing 60 trading days from the end of the performance measurement period (March 1, 2024) against the comparable period from the beginning of the performance measurement period (March 1, 2021), the grant recipient would receive a 2% increase in the number of shares above target (up to a maximum cap of 200% of the target award). For each 1% below such index’s performance, the grant recipient would receive a 2% decrease in the number of shares. No PSUs will be earned if IPG’s common stock falls below the performance of such index by more than 25%. As a result, TSR PSUs, if earned, will vest at or between the threshold (50% of target) and maximum (200% of target) levels depending on the performance of our stock’s relative total stockholder return.
For the PSUs based upon operating cash flow ("OCF PSUs"), the value of the PSU is based upon the ratio of the Company's operating cash flow to adjusted net income measured over a three-year performance period starting on January 1, 2021, and ending on December 31, 2023 (the "OCF Ratio"). For such awards, the OCF Ratio is set annually based upon the annual budget approved by the Board for the then present year with the intent to incentivize and reward executives and other senior employees for managing working capital appropriately. The performance of the actually achieved OCF Ratio to the target ratio for each individual year in the performance period is averaged over the three-year performance period to calculate the final award earned. Performance below the target would decrease the award, subject to a minimum performance level below which no award would be earned, and performance above the target would increase the award, subject to a maximum cap of 200% of the target award.
RSUs vest over a four-year period and encourage retention. PSUs, which vest over a three-year period, also serve as a valuable retention tool. RSUs and PSUs granted in 2021 are entitled to dividends, should any be paid. Any dividends on shares underlying the RSUs and PSUs do not vest until the awards vest.
In 2021, the Compensation Committee used competitive market data from the total compensation study of peer companies to gain perspective of appropriately competitive executive compensation. The Compensation Committee analyzed several aspects of the equity grant program, including (i) the degree to which executives have incentives to remain employed by the Company through unvested award value and (ii) the aggregate equity usage in terms of (a) annual usage, typically called burn rate and (b) cumulative equity delivery, typically called overhang, to determine the dilutive effect of equity awards on investors. The majority of outstanding equity award holdings of the executives were allocated to unvested shares in the aggregate, and all such executives had a minimum of two years’ worth of annual award values in unvested equity value. Based upon this information, Aon advised the Compensation Committee that our equity program provided strong retention incentives.
47

2021 Compensation of Named Executive Officers
In May 2021, in connection with Dr. Scherbakov's appointment as CEO, the Compensation Committee approved an additional grant to Dr. Scherbakov of $2,000,000 of long-term incentives in the form of equity awards consisting of RSUs and PSUs, each weighted 50%. The RSUs vest 25% on each anniversary of May 7, 2021 and the PSUs vest May 7, 2024, should any vest at all. The PSUs are half TSR PSUs and half OCF PSUs. The PSUs have the same performance criteria and performance periods as those granted to Dr. Scherbakov on February 19, 2021.
The table below provides information on grants of service-based RSUs and performance-based TSR PSUs and OCF PSUs to the NEOs in 2021. Except for awards granted to Dr. Scherbakov in May 2021 as described above, RSUs in the table below vest 25% on each anniversary of March 1, 2021, and PSUs vest on March 1, 2024, the last day of the three-year performance measurement period, should any vest at all.

Name | Equity Incentive as a Percentage of Base Salary (%) | Service-Based Restricted Stock Units (#) | TSR PSUs (at Target) (#) | TSR PSUs Range (Based upon Achievement) (#) | OCF PSUs (at Target) (#) | OCF PSUs Range (Based upon Achievement) (#)
Eugene A. Scherbakov | 525 | 10,305 | 5,152 | 0 - 10,304 | 5,152 | 0 - 10,304
Timothy P.V. Mammen | 300 | 3,231 | 1,615 | 0 - 3,230 | 1,615 | 0 - 3,230
Angelo P. Lopresti | 275 | 2,669 | 1,334 | 0 - 2,668 | 1,334 | 0 - 2,668
Alexander Ovtchinnikov | 275 | 2,644 | 1,322 | 0 - 2,644 | 1,322 | 0 - 2,644
Felix Stukalin | 283 | 2,663 | 1,331 | 0 - 2,662 | 1,331 | 0 - 2,662

Actual Performance of Performance-Based Stock Units.
TSR PSUs granted in 2018 and 2019 vested in March 2021 and 2022, respectively, but IPG performance was below the respective thresholds so no shares were paid out for both awards. No information is available yet on the performance of TSR PSUs and OCF PSUs granted in 2020, 2021 and 2022, as they will not vest until March 2023, 2024 and 2025, respectively. The lack of a payout for the 2018 and 2019 TSR PSUs illustrates both the challenging performance targets that the Compensation Committee established as part of the 2018 and 2019 PSU awards, as well as the alignment of the NEOs’ pay with Company performance.
2022 Update. For 2022, long-term incentive levels remained the same as 2021, except that the Compensation Committee changed the performance metrics for PSUs to organic revenue growth and operating margin. The Committee chose these two measures because they are generally accepted as two fundamental drivers of sustained stockholder value and provide clearer line-of-sight measurements than many alternative measures. The Compensation Committee approved 2022 awards comprised of service-based RSUs (50%) and PSUs based upon organic revenue growth (at target, 25%), and operating margin (at target, 25%). Additionally, the Compensation Committee determined to vest RSUs granted in 2022 over three years after considering peer vesting practices and desiring for the Company's compensation programs to be competitive to attract and retain the best talent in a competitive market.
48 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

2021 Compensation of Named Executive Officers
Other Compensation
Severance Benefits. The severance benefits that we offer to our NEOs assist us in recruiting and retaining talented individuals and are consistent with the range of severance benefits offered by our peer group. The severance provisions of our NEO employment agreements are summarized in Potential Payments upon Termination or Change in Control below.
Retirement Benefits. We do not offer an executive retirement plan or a non-qualified deferred compensation plan. Executives in the United States are eligible to participate in our 401(k) retirement savings plan on the same terms as all other U.S. employees. Our 401(k) retirement savings plan is a tax-qualified plan and therefore is subject to certain Internal Revenue Code limitations on the dollar amounts of deferrals and company contributions that can be made to plan accounts. These limitations apply to our more highly-compensated employees (including the NEOs). We made matching contributions to our employees at a rate of 50% of deferrals subject to a maximum of 6% of eligible compensation under the 401(k) retirement savings plan, including the NEOs, who participate in the plan as set forth in the Summary Compensation Table. Dr. Scherbakov has historically participated in a German government-sponsored retirement program.
Moving and Living Expenses. In 2021, in connection with his appointment as CEO, the Company agreed to pay or reimburse Dr. Scherbakov for his expenses related to moving to and his employment in the United States, including but not limited to relocation assistance, automobile, housing costs, health and disability insurance, tax preparation, repatriation and air transportation costs for him and his spouse, which will be tax-grossed up. Dr. Scherbakov kept his residence in Germany where he spends a portion of his time managing the Company.
Personal Benefits. Our executives are eligible to participate in employee benefit plans, including medical, dental, life and disability insurance and vacation plans as well as an employee stock purchase plan, which is intended to be qualified under Section 423 of the Internal Revenue Code. The employee stock purchase plan allows participants to purchase Company shares at a price equal to 85% of the lesser of the fair market value at the first day or last day of the six month offering period, subject to limitations on the amount of shares. These plans generally are available to all salaried employees and do not discriminate in favor of executives. Benefits are intended to be competitive with the overall market in order to facilitate attraction and retention of high-quality employees.
The Compensation Committee compared the Company’s executive perquisites policies against the 2021 peer group and made no changes. The Company provides the use of a corporate aircraft to the CEO and other executives for business travel integral to the performance of their duties. Executives are encouraged to use the aircraft for efficiency, safety and security. However, executives are not allowed to use the aircraft for personal use that has not been paid for, except that family and other guests may accompany executives on the aircraft for business travel and except for compassion circumstances. Until his death, the Company provided Dr. Gapontsev with a car and driver in the United States so that he could use his travel time for company purposes. The Company similarly provides Dr. Scherbakov use of an automobile in the United States and Germany.
Executive Compensation Decision-Making
Role of Compensation Committee
The Compensation Committee determines, approves and administers the compensation programs for our executive officers, including our NEOs. The Compensation Committee recommends to the independent directors the CEO’s annual base salary, annual incentive opportunity and long-term incentive opportunity. The independent directors approve the CEO’s compensation and our Compensation Committee approves the compensation for other executive officers in consultation with our CEO. Our Compensation Committee is also responsible for making recommendations to the Board with respect to the adoption of equity plans and certain other benefit plans. The Compensation Committee and the independent directors meet in executive sessions when determining executive compensation.
The Compensation Committee may delegate authority whenever it deems appropriate. In 2021, the Compensation Committee delegated authority to grant equity awards for non-executives to the CEO, subject to certain conditions, including amounts of awards and review of awards by the Compensation Committee.
Our Compensation Committee’s policy is to set executive pay in accordance with the objectives of the Company’s compensation programs as described above. In the Compensation Committee’s view, the Company’s executive compensation program provides an overall level of compensation opportunity that is competitive with peer companies. Actual compensation levels may be greater or less than target compensation levels provided by similar companies based upon annual and long-term Company performance, as well as individual performance, contributions, skills, seniority, knowledge, experience and responsibilities.
49

2021 Compensation of Named Executive Officers
Role of Management
The CEO participates in the establishment of compensation levels and payouts for individual performance for other NEOs. He assesses the performance of all NEOs and recommends to the Compensation Committee the overall levels of achievement and personal performance in the year. Upon request, the NEOs provide supplemental material to the Compensation Committee to assist in the determination and implementation of compensation, policies and practices. The CEO is not involved in decisions regarding the setting of any component of his compensation. The CEO and other members of senior management attend Compensation Committee meetings at the invitation of the Compensation Committee.
Role of Independent Consultant
The Compensation Committee engaged Aon's Human Capital Solutions practice, a division of Aon plc ("Aon"), an independent compensation consultant, to conduct a comprehensive review and analysis of our executive and non-employee director compensation programs and to make recommendations for compensation related to 2021. The consultation included non-executive compensation data and valuation services for equity incentives. Aon does not perform any other work for the Company. The Compensation Committee reviews the independence of Aon in light of SEC rules and Nasdaq listing standards regarding compensation consultants. The Compensation Committee believes that there were no actual or potential conflicts of interest with Aon in 2021.
Pay Positioning Strategy and Peer Group
Consistent with prior years, in 2021 the Compensation Committee used competitive compensation data from the annual total compensation study of peer companies to inform its decisions about overall compensation opportunities and specific compensation elements. Aon performed an analysis of similarly-situated public companies, supplemented the peer group with published survey data providing a broad market representation of companies and deeper position reporting, as well as set parameters for the peer group study. Additionally, the Committee used multiple reference points when establishing targeted compensation levels. Within the comparative framework, the primary data was the named peer group of specific peers selected by the Compensation Committee and the secondary data was broader, size-appropriate comparisons in the high technology industry using Aon/Radford Global Technology Survey data. The Committee does not benchmark specific compensation elements or total compensation to any specific percentile relative to the peer companies or the broader United States market. Instead, the Committee applies judgment and discretion in establishing targeted pay levels, taking into account not only competitive market data, but also factors such as Company, business and individual performance, scope of responsibility, critical needs and skill sets, leadership potential, length of tenure and succession planning. No single factor takes precedence over any other, nor is any formula used in making these decisions.
The peer companies selected by the Compensation Committee are companies that operate in the semiconductor equipment and electronic manufacturing industries, and are comparable in terms of revenue, market capitalization and headcount.
For 2021, the peer companies were:

Barnes Group, Inc. | Cognex Corporation | Coherent, Inc.
Dolby Laboratories, Inc. | Donaldson Company, Inc. | Entegris, Inc.
FLIR Systems, Inc. | Graco, Inc. | IDEX Corporation
II-VI Incorporated | ITT, Inc. | Lumentum Holdings Inc.
MKS Instruments, Inc. | National Instruments, Inc. | Nordson Corporation
Teradyne, Inc. | Trimble Navigation Limited | Waters Corporation
Watts Water Technologies, Inc. |  |

The Compensation Committee reviews this peer group annually with input from Aon to ensure that the comparisons are meaningful. In this review, the Compensation Committee considers several factors in developing a peer group: it considers the current peer group to determine appropriateness, the peers used by institutional governance advisors, the companies that list our company as a peer to understand crossover peers and broader research based upon established selection criteria to identify potential future peers. The Committee then develops criteria for business sector, including but not limited to revenue, operating income and market capitalization. Aon also supplements its peer analysis with the data from a
50 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

2021 Compensation of Named Executive Officers
broader list of high-technology public company participants in the AON/Radford Global Technology Survey targeting technology companies with comparable revenue levels. Companies that are no longer publicly traded are omitted from the peer group. Based upon the process and applying the criteria above, the Compensation Committee, with input from Aon, determined the historical peer group continued to be appropriate for 2021.
COMPANY VS. PEER GROUP
For 2021 peer group selection purposes, the Company, with input from Aon, determined to use IPG and peer group financials as of December 31, 2019, to omit the impact of the Covid-19 global pandemic as much as possible. The below figures are as of December 31, 2019:
2022 Update. For 2022 compensation determinations, the Compensation Committee reviewed the analysis from Aon regarding the Company’s peer group. Aon performed an analysis of similarly-situated public companies, supplemented the peer group with published survey data providing a broad market representation of companies, as well as set parameters for the peer group study. For 2022, the analysis by Aon proposed adding Littlefuse, Inc. and Novanta, Inc. and removing FLIR Systems, Inc. because FLIR was acquired in 2021. The Compensation Committee approved the proposed changes to the peer group for 2022 compensation determinations.
Other Factors Affecting Compensation
Tax Deductibility under Section 162(m). Section 162(m) of the Internal Revenue Code (“Section 162(m)”) limits the deductibility for federal income tax purposes of certain compensation paid in any year by a publicly held corporation to its “covered employees” as defined by Section 162(m) (generally, our current and former NEOs) to $1 million per executive (the “$1 million cap”). The Compensation Committee believes it is appropriate to retain the flexibility to authorize payments of compensation that may exceed the $1 million cap if, in the Compensation Committee’s judgment, it is in the Company’s best interest to do so. We generally will continue to emphasize performance-based compensation, even though it may no longer be deductible.
Accounting Considerations. We consider the accounting implications of our executive compensation program. In addition, accounting treatment is just one of many factors impacting plan design and pay determinations. Our executive compensation program is designed to achieve a favorable accounting and tax treatment so long as doing so does not conflict with the intended plan design or program objectives.
51

2021 Compensation of Named Executive Officers
Compensation Risk
Management conducts an annual risk assessment of the Company’s compensation policies and practices for all employees, including non-executives, and reports its findings to the Compensation Committee. In 2021 management concluded that the Company’s compensation policies and practices are balanced and do not motivate imprudent risk taking. Management believes that the Company's compensation policies do not create risks that are reasonably likely to have a material adverse effect on the Company.
In reaching this conclusion, they considered the following factors:
•our compensation program is designed to provide a mix of both fixed and variable incentive compensation;
•our senior executives are subject to stock ownership guidelines, which we believe incentivize our executives to consider the long-term interests of the Company and our stockholders and discourage excessive risk-taking that could negatively impact our stock price;
•our senior executives are subject to compensation recovery policy, which discourages excessive risk-taking that could negatively affect our stock price;
•our incentive compensation programs are designed with vesting terms that are relatively consistent, spread out over several years, and do not contain steep payout “cliffs” that might encourage short-term business decisions in order to meet a vesting or payout threshold; and
•our senior executive incentive compensation program caps the amounts that may be paid for performance above target level.
Other Policies
Anti-Hedging and Limitations on Pledging of Company Stock. The Board adopted policies prohibiting hedging transactions and limiting the pledging of our common stock. Under our insider trading policy, no director or employee may engage in shorting shares of our common stock or any type of securities that we may issue, or buying or selling puts, calls or derivatives related to our common stock. A director or officer of the Company may not pledge shares constituting more than 20% of his or her total stock ownership. Pledges of shares constituting 20% or less of total stock ownership are subject to certain conditions.
Stock Ownership Guidelines. The Board adopted stock ownership guidelines to closely align the interests of our executives with those of our long-term stockholders. Generally, the CEO must hold five times his annual salary in company equity, and senior executive officers must hold at least two times their respective annual salaries in company equity. For more information, including the types of equity that count toward our stock ownership guidelines, see Proposal 1 - Director Compensation - Director and Executive Officer Stock Ownership Guidelines.
Clawback Policies. The Board adopted compensation recovery policy that allows the Company to recapture cash and equity performance-based compensation from executives if the amount of the award was based upon achieving certain financial results that were later restated due to the participant’s misconduct. In addition, all equity awarded to employees since 2007 contain a provision under which employees may be required to forfeit equity awards or profit from equity awards if they engage in certain conduct, including competing against the Company, disclosing confidential information, or soliciting its employees or customers.
52 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Executive Compensation Tables

Summary Compensation Table
The following table provides information regarding compensation earned by the NEOs for the fiscal years indicated below:

Name and Principal Position | Year | Salary ($) | Bonus ($) | Stock Awards ($)(1) | Option Awards ($)(1) | Non-Equity Incentive Plan Compensation ($)(2) | All Other Compensation ($)(3) | Total ($)
Eugene Scherbakov Chief Executive Officer(4)(5) | 2021 | 803,200 |  | — |  | 4,406,457 |  | — |  | 1,919,896 |  | 155,298 |  | 7,284,851 |
2020 | 627,819 |  | — |  | 2,441,338 |  | — |  | 573,604 |  | 25,554 |  | 3,668,315 |
2019 | 616,730 |  | — |  | 2,152,254 |  | 930,281 |  | 154,155 |  | 24,647 |  | 3,878,067 |
Timothy P.V. Mammen Chief Financial Officer and Senior Vice President | 2021 | 505,300 |  | — |  | 1,534,952 |  | — |  | 909,600 |  | 10,632 |  | 2,960,484 |
2020 | 481,200 |  | — |  | 1,504,074 |  | — |  | 375,900 |  | 26,561 |  | 2,387,735 |
2019 | 481,200 |  | — |  | 1,040,106 |  | 449,556 |  | 96,240 |  | 9,642 |  | 2,076,744 |
Angelo P. Lopresti Senior Vice President, General Counsel and Secretary | 2021 | 455,400 |  | — |  | 1,267,921 |  | — |  | 819,700 |  | 12,312 |  | 2,555,333 |
2020 | 442,100 |  | — |  | 1,266,637 |  | — |  | 323,200 |  | 12,162 |  | 2,044,099 |
2019 | 442,100 |  | — |  | 906,066 |  | 391,686 |  | 88,420 |  | 10,722 |  | 1,838,994 |
Alexander Ovtchinnikov Senior Vice President, Chief Technology Officer | 2021 | 451,200 |  | — |  | 1,256,284 |  | — |  | 812,100 |  | 14,244 |  | 2,533,828 |
2020 | 438,100 |  | — |  | 1,255,095 |  | — |  | 320,300 |  | 39,122 |  | 2,052,617 |
2019 | 438,100 |  | — |  | 897,754 |  | 388,154 |  | 87,620 |  | 10,722 |  | 1,882,350 |
Felix Stukalin Senior Vice President, Chief Operating Officer | 2021 | 441,600 |  | — |  | 1,265,070 |  | — |  | 794,900 |  | 14,244 |  | 2,515,814 |
2020 | 424,700 |  | — |  | 1,264,094 |  | — |  | 313,400 |  | 25,353 |  | 2,027,547 |
2019 | 428,700 |  | — |  | 878,705 |  | 379,790 |  | 85,740 |  | 15,714 |  | 1,788,649 |
Valentin P. Gapontsev Former Chief Executive Officer and Executive Chair(5)(6) | 2021 | 846,154 |  | — |  | — |  | — |  | 2,273,116 |  | 134,764 |  | 3,254,034 |
2020 | 930,000 |  | — |  | — |  | — |  | 934,900 |  | 79,000 |  | 1,943,900 |
2019 | 930,000 |  | — |  | — |  | — |  | 255,750 |  | 66,234 |  | 1,251,984 |

(1)The Company last granted stock options in 2019. In 2020 and 2021, the Company instead granted solely PSUs and service-based RSUs, which are reflected in the Stock Awards column for 2020 and 2021. The value of the PSUs is based on the probable outcome of the performance conditions (at the grant date) in accordance with ASC Topic 718 assuming no forfeiture. For PSUs granted in 2021, the values assuming the highest level of performance conditions will be achieved, as limited by the 600% value cap, are $13,087,440, $4,673,970, $3,860,730, $3,826,002, and $3,852,048 for Dr. Scherbakov, Messrs. Mammen and Lopresti, Dr. Ovtchinnikov, and Mr. Stukalin, respectively. There is no assurance that any of the performance targets will be achieved, that the service-based awards will vest or that the any of the recipients will realize the values listed above.
(2)Represents amounts earned under our AIP for services rendered in 2021, 2020 and 2019, respectively.
(3)The amount in 2021 for Dr. Gapontsev consists of premiums paid for group life insurance, the expense of an automobile and driver ($31,812) provided by us for his transportation to the Company’s headquarters and $96,154 in a one-time cash payment for accrued but unused paid time following his death. The amount in 2021 for Dr. Scherbakov consists of the expense of automobiles in Germany and the United States ($44,328), housing provided by us in connection with relocation to the United States ($63,191), and tax-gross ups to cover additional expenses in connection with his relocation to the United States ($47,779).
(4)Dr. Scherbakov was Chief Operating Officer, Managing Director of IPG Laser GmbH, and Senior Vice President, Europe prior to his appointment as CEO on May 4, 2021.
(5)Portions of the amounts paid to Drs. Gapontsev and Scherbakov were denominated in Euros and Rubles. Dr. Scherbakov’s salary as Chief Operating Officer for 2019, 2020 and 2021 and as Chief Executive Officer in 2021 was approved in Euro. Amounts paid in foreign currencies were translated into U.S. Dollars at the average daily exchange rates for the full years. The average daily rates in 2021, 2020 and 2019 for the Euro were 0.85, 0.88, and 0.89, respectively, and in 2020 and 2019 for the Ruble were 72.13 and 64.66, respectively. As a result of compensation being paid in one or more currencies that fluctuate against the U.S. Dollar, the amount of salary paid may vary slightly from the salary stated in an employment agreement or approved by the Compensation Committee.
(6)On May 4, 2021, Dr. Gapontsev transitioned from CEO to the role of Executive Chair. Dr. Gapontsev passed away on October 22, 2021.
53

Executive Compensation Tables
2021 Grants of Plan-Based Awards

Name | Grant Date | Estimated Possible Payouts Under Non-Equity Incentive Plan Awards ($)(1) |  | Estimated Future Payouts Under Equity Incentive Plan Awards (#)(2) | All Other Stock Awards: Number of Shares of Stock or Units (#)(3) | All Other Option Awards: Number of Securities Underlying Options (#) | Exercise or Base Price of Option Awards ($/Share) | Grant Date Fair Value of Stock and Option Awards ($)(4)
Threshold | Target | Maximum |  | Threshold | Target | Maximum
Eugene Scherbakov(5) | 2/19/2021 | 373,263 |  | 853,301 |  | 1,919,939 |  |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
2/19/2021 | — |  | — |  | — |  |  | 2,618 |  | 5,236 |  | 10,472 |  | — |  | — |  | — |  | 1,262,792 |
2/19/2021 | — |  | — |  | — |  |  | — |  | — |  | — |  | 5,237 |  | — |  | — |  | 1,225,301 |
| 5/7/2021 | — |  | — |  | — |  |  | 2,534 |  | 5,068 |  | 10,136 |  | — |  | — |  | — |  | 918,448 |
| 5/7/2021 | — |  | — |  | — |  |  | — |  | — |  | — |  | 5,068 |  | — |  | — |  | 999,916 |
Timothy P.V. Mammen | 2/19/2021 | 176,855 |  | 404,240 |  | 909,540 |  |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
2/19/2021 | — |  | — |  | — |  |  | 1,615 |  | 3,230 |  | 6,460 |  | — |  | — |  | — |  | 778,995 |
2/19/2021 | — |  | — |  | — |  |  | — |  | — |  | — |  | 3,231 |  | — |  | — |  | 755,957 |
Angelo P. Lopresti | 2/19/2021 | 159,390 |  | 364,320 |  | 819,720 |  |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
2/19/2021 | — |  | — |  | — |  |  | 1,334 |  | 2,668 |  | 5,336 |  | — |  | — |  | — |  | 643,455 |
2/19/2021 | — |  | — |  | — |  |  | — |  | — |  | — |  | 2,669 |  | — |  | — |  | 624,466 |
Alexander Ovtchinnikov | 2/19/2021 | 157,920 |  | 360,960 |  | 812,160 |  |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
2/19/2021 | — |  | — |  | — |  |  | 1,322 |  | 2,644 |  | 5,288 |  | — |  | — |  | — |  | 637,667 |
2/19/2021 | — |  | — |  | — |  |  | — |  | — |  | — |  | 2,644 |  | — |  | — |  | 618,617 |
Felix Stukalin | 2/19/2021 | 154,560 |  | 353,280 |  | 794,880 |  |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
2/19/2021 | — |  | — |  | — |  |  | 1,331 |  | 2,662 |  | 5,324 |  | — |  | — |  | — |  | 642,008 |
2/19/2021 | — |  | — |  | — |  |  | — |  | — |  | — |  | 2,663 |  | — |  | — |  | 632,062 |
Valentin P. Gapontsev | 2/19/2021 | 546,880 |  | 1,250,000 |  | 2,812,500 |  |  | — |  | — |  | — |  | — |  | — |  | — |  | — |

(1)Amounts shown include possible payouts under the AIP for 2021 financial performance at the three performance measures plus individual performance at the maximum level for each. The performance measures used in determining AIP payments are discussed in Compensation Discussion and Analysis-Annual Incentives above. Actual amounts paid for 2021 performance are shown in the “Non-Equity Incentive Plan Compensation” column in the Summary Compensation Table above.
(2)For a description of the PSUs, see Compensation Discussion and Analysis–Long-Term Incentives above.
(3)The amounts listed reflect service-based RSUs granted under our 2006 Incentive Compensation Plan, which vest in four annual installments commencing on March 1, 2022.
(4)Valuation based on the fair value of such awards as of the grant date determined pursuant to ASC Topic 718. The assumptions that we used with respect to the valuation of equity awards are set forth in Note 15 to our Consolidated Financial Statements in our Annual Report. Regardless of the value placed on an equity award on the grant date, the actual value of the equity award will depend on the market value of our common stock when such equity award vests, and, with respect to PSUs, on the Company's performance relative to the applicable performance metrics under such PSUs, as described above under Compensation Discussion and Analysis-Long Term Incentives. For informational purposes, if the maximum level of performance were achieved for the PSUs, the values as limited by the 600% value cap, are $13,087,440, $4,673,970, $3,860,730, $3,826,002, and $3,852,048 for Dr. Scherbakov, Messrs. Mammen and Lopresti, Dr. Ovtchinnikov, and Mr. Stukalin, respectively.
(5)Dr. Scherbakov was Chief Operating Officer, Managing Director of IPG Laser GmbH, and Senior Vice President, Europe prior to his appointment as CEO on May 4, 2021. As a result, Dr. Scherbakov's non-equity incentive opportunities under the AIP were pro-rated based on the amount of time he served in each position during fiscal 2021. The amount reported in threshold, target and maximum of non-equity incentive plan awards set forth in the table above reflects pro-rated threshold, target and maximum amounts available under AIP in respect of time served as Chief Operating Officer and CEO, respectively.
54 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Executive Compensation Tables
2021 Outstanding Equity Awards at Fiscal Year-End

|  | Option Awards(1) |  | Stock Awards(1)
Name | Grant Date | Securities Underlying Unexercised Options Exercisable (#) | Securities Underlying Unexercised Options Unexercisable (#) | Option Exercise Price ($)(2) | Option Expiration Date |  | Number of Shares or Units of Stock That Have Not Vested (#) | Market Value of Shares or Units of Stock That Have Not Vested ($)(3) | Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#)(1)(4) | Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested ($)(4)
Eugene Scherbakov | 2/14/2012 | 1,500 |  | — |  | 58.65 |  | 2/13/2022 |  | — |  | — |  | — |  | — |
3/1/2013 | 3,000 |  | — |  | 60.11 |  | 2/28/2023 |  | — |  | — |  | — |  | — |
2/28/2014 | 13,000 |  | — |  | 71.77 |  | 2/27/2024 |  | — |  | — |  | — |  | — |
2/25/2015 | 7,326 |  | — |  | 97.65 |  | 2/24/2025 |  | — |  | — |  | — |  | — |
2/18/2016 | 7,592 |  | — |  | 81.89 |  | 2/17/2026 |  | — |  | — |  | — |  | — |
2/17/2017 | 10,367 |  | — |  | 119.50 |  | 2/16/2027 |  | — |  | — |  | — |  | — |
2/22/2018 | 10,308 |  | 3,436 |  | 239.72 |  | 2/21/2028 |  | 1,003 |  | 172,656 |  | — |  | — |
2/15/2019 | 8,954 |  | 8,954 |  | 154.88 |  | 2/14/2029 |  | 3,107 |  | 534,839 |  | 12,428 |  | 2,139,356 |
2/19/2020 | — |  | — |  | — |  | — |  |  | 6,105 |  | 1,050,915 |  | 16,276 |  | 2,801,751 |
2/19/2021 | — |  | — |  | — |  | — |  |  | 5,237 |  | 901,497 |  | 10,472 |  | 1,802,650 |
5/7/2021 | — |  | — |  | — |  | — |  |  | 5,068 |  | 872,406 |  | 10,136 |  | 1,744,811 |
Timothy P.V. Mammen | 2/22/2018 | 4,982 |  | 1,660 |  | 239.72 |  | 2/21/2028 |  | 485 |  | 83,488 |  | — |  | — |
2/15/2019 | 4,327 |  | 4,327 |  | 154.88 |  | 2/14/2029 |  | 1,501 |  | 258,382 |  | 6,006 |  | 1,033,873 |
2/19/2020 | — |  | — |  | — |  | — |  |  | 3,761 |  | 647,419 |  | 10,028 |  | 1,726,220 |
2/19/2021 | — |  | — |  | — |  | — |  |  | 3,231 |  | 556,184 |  | 6,460 |  | 1,112,024 |
Angelo P. Lopresti | 2/25/2015 | 5,661 |  | — |  | 97.65 |  | 2/24/2025 |  | — |  | — |  | — |  | — |
2/18/2016 | 5,861 |  | — |  | 81.89 |  | 2/17/2026 |  | — |  | — |  | — |  | — |
2/17/2017 | 7,184 |  | — |  | 119.50 |  | 2/16/2027 |  | — |  | — |  | — |  | — |
2/22/2018 | 4,340 |  | 1,446 |  | 239.72 |  | 2/21/2028 |  | 422 |  | 72,643 |  | — |  | — |
2/15/2019 | 3,770 |  | 3,770 |  | 154.88 |  | 2/14/2029 |  | 1,308 |  | 225,159 |  | 5,232 |  | 900,636 |
2/19/2020 | — |  | — |  | — |  | — |  |  | 3,168 |  | 545,340 |  | 8,444 |  | 1,453,550 |
2/19/2021 | — |  | — |  | — |  | — |  |  | 2,669 |  | 459,442 |  | 5,336 |  | 918,539 |
Alexander Ovtchinnikov | 2/17/2017 | 7,119 |  | — |  | 119.50 |  | 2/16/2027 |  | — |  | — |  | — |  | — |
2/22/2018 | 4,301 |  | 1,433 |  | 239.72 |  | 2/21/2028 |  | 418 |  | 71,955 |  | — |  | — |
2/15/2019 | 3,736 |  | 3,736 |  | 154.88 |  | 2/14/2029 |  | 1,296 |  | 223,093 |  | 5,184 |  | 892,374 |
2/19/2020 | — |  | — |  | — |  | — |  |  | 3,138 |  | 540,175 |  | 8,368 |  | 1,440,468 |
2/19/2021 | — |  | — |  | — |  | — |  |  | 2,644 |  | 455,138 |  | 5,288 |  | 910,276 |
Felix Stukalin | 3/1/2013 | 5,000 |  | — |  | 60.11 |  | 2/28/2023 |  | — |  | — |  | — |  | — |
2/28/2014 | 10,000 |  | — |  | 71.77 |  | 2/27/2024 |  | — |  | — |  | — |  | — |
2/25/2015 | 5,661 |  | — |  | 97.65 |  | 2/24/2025 |  | — |  | — |  | — |  | — |
2/18/2016 | 5,861 |  | — |  | 81.89 |  | 2/17/2026 |  | — |  | — |  | — |  | — |
2/17/2017 | 6,900 |  | — |  | 119.50 |  | 2/16/2027 |  | — |  | — |  | — |  | — |
2/22/2018 | 4,208 |  | 1,403 |  | 239.72 |  | 2/21/2028 |  | 409 |  | 70,405 |  | — |  | — |
2/15/2019 | 3,656 |  | 3,655 |  | 154.88 |  | 2/14/2029 |  | 1,268 |  | 218,274 |  | 5,074 |  | 873,438 |
2/19/2020 | — |  | — |  | — |  | — |  |  | 3,161 |  | 544,135 |  | 8,428 |  | 1,450,796 |
2/19/2021 | — |  | — |  | — |  | — |  |  | 2,663 |  | 458,409 |  | 5,324 |  | 916,473 |

(1)The vesting dates assume the continued service of the NEO through the applicable vesting date. Service-based stock options granted in 2018 and 2019 and all service-based RSUs vest in four annual installments commencing on March 1 of the year following the grant. PSUs
55

Executive Compensation Tables
granted in 2019, 2020 and 2021 vest in one installment on March 1, 2022, March 1, 2023 and March 1, 2024, respectively. However, the RSUs granted on May 7, 2022 to Dr. Scherbakov vest in four annual installments commencing on May 7, 2023 and PSUs granted on May 7, 2022 to Dr. Scherbakov vest in one installment on May 7, 2024.
(2)Represents the closing common stock price of a share on the grant date.
(3)Based upon the closing common stock price on December 31, 2021, which was $172.14 per share.
(4)The PSU performance measurement periods end March 1, 2022, 2023 and 2024 for units granted in 2019, 2020, and 2021, respectively. The number of unearned awards range from 0% to 200% based upon achievement of performance metrics and the amounts presented above assume attainment of the maximum performance levels (200%) not limited by dollar value caps. PSUs have dollar payout caps of 600% of the value of the target award on the date of grant. PSUs granted in 2019, which vested on March 1, 2022, did not result in a payout.
56 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Executive Compensation Tables
Option Exercises and Stock Vested in 2021
The following table provides information on NEO stock option exercises and vesting of RSUs during 2021. PSUs granted in 2018 vested in March 2021, but IPG performance fell below threshold, so no shares were paid out for these awards.

| Option Awards |  | Stock Awards
Name | Number of Shares Acquired on Exercise (#) | Value Realized on Exercise ($)(1) |  | Number of Shares Acquired on Vesting (#) | Value Realized on Vesting ($)(2)
Eugene A. Scherbakov | — | — |  | 5,438 | 1,244,051
Timothy P.V. Mammen | 16,125 | 2,205,232 |  | 3,208 | 733,894
Angelo P. Lopresti | — | — |  | 2,719 | 622,026
Alexander Ovtchinnikov | — | — |  | 2,694 | 616,306
Felix Stukalin | 8,000 | 1,176,557 |  | 2,662 | 608,986
Valentin P. Gapontsev | — | — |  | — | —

(1)The value realized is based on the difference between the reported closing common stock price on the date of exercise and the exercise price of the stock option.
(2)The value realized is based on the closing common stock prices on the vesting dates of service-based RSUs.
Potential Payments upon Termination or Change in Control
The Company has entered into employment agreements with each of the NEOs, effective through December 31, 2022. Upon expiration, the employment agreements will automatically renew for successive one-year periods, unless the Company or a NEO provides written notice of non-renewal at least six months prior to the end of the then-current term. In the event of a change in control, the agreements would extend through the second anniversary of the change in control. The employment agreements set the annual base salaries and stipulate that the Compensation Committee may adjust the salaries annually, as noted in Compensation Discussion and Analysis - Base Salary above. The agreements entitle these executive officers to participate in bonus plans, standard insurance plans such as life, short-term disability and long-term disability insurance and retirement benefits, such as the 401(k) retirement savings plan and equity award plans described above, on similar terms and on a similar basis as such benefits are available to executives at similar levels within the Company.
If the Company terminates the employment of any of the NEOs without cause (as defined in the respective employment agreements) or any of the NEOs terminates his employment for good reason (as defined in the respective employment agreements) (“cause” and “good reason” are referred to below as “Involuntary Terminations”), then the NEO would receive:
•continuation of salary for eighteen months;
•a portion of the annual bonus that the NEO would have received had he remained employed through the end of the applicable bonus period, based on actual performance, including the individual performance element (such portion based on the percentage of the year that the NEO was employed by the Company);
•cash reimbursement for continuation of health benefits for up to eighteen months; and
•accelerated vesting of equity compensation awards that otherwise would have vested within twelve months following the termination of employment.
57

Executive Compensation Tables
Upon an Involuntary Termination within twenty-four months following a change in control of the Company, the NEO would be entitled to continuation of salary and reimbursement of COBRA premiums for health benefits for twenty-four months, the pro-rated bonus for the year of termination plus a payment of two times the average annual bonus paid to the NEO for the three full years preceding the year of termination. Under the employment agreements, all equity awards vest fully upon an Involuntary Termination that occurs within two years of a change in control. Upon a change in control, the NEOs’ employment periods under the agreements would automatically be extended to the second anniversary of the change in control if such date is later than expiration of the current term.
If the total value of all payments and benefits, including any equity vesting (“total payments”), made to a NEO following a change in control would result in an excise tax under the provisions of Internal Revenue Code Section 4999 (the “golden parachute tax”), the total payments will be reduced so that the maximum amount of total payments (after reduction) is $1.00 less than the amount that would cause the total payments to be subject to the golden parachute tax; provided, however, that the total payments will only be reduced to the extent that the after-tax value of amounts received by the officer after application of the above reduction would exceed the after-tax value of the total payments received without application of such reduction (so called “best after-tax treatment”).
If the employment period of any of the NEOs terminates and the Company does not offer such NEO continued employment in the same or a substantially similar position or in a higher position than the NEO's position at the end of the employment period and at a compensation level that is the same or substantially similar to the compensation level in effect at the end of the employment period, then such NEO may resign from employment and would receive continuation of salary and health benefits for twelve months, plus a pro-rated bonus for the year of termination.
If a NEO's employment is terminated by death or disability, the NEO would receive a pro-rated bonus for the year of termination. Under the employment agreements, the Company would not be obligated to make any cash payments if employment were terminated by the Company for cause or by the NEO other than for good reason. Additionally, if the NEO's employment is terminated due to death, the non-vested portions of stock options, RSUs and PSUs would immediately vest.
Severance payments to the NEOs are conditioned upon the release of claims by the NEO in favor of the Company. Each of the NEOs entered into a separate restrictive agreement that prohibits each from competing with the Company for a period of one year after the termination of his employment with the Company for any reason and from hiring or attempting to hire the Company’s employees or soliciting customers or suppliers of the Company for a period ending eighteen months following the termination of his employment for any reason. Each of the NEOs is entitled to receive his base salary for the period during which the Company enforces the non-competition provisions of the agreement but not for more than one year following termination of his employment.
58 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Executive Compensation Tables
The following table provides information regarding compensation and benefits that would be payable to our NEOs as of December 31, 2021, upon an Involuntary Termination absent a change in control and preceded by a change in control and upon terminations in other circumstances. The incentive plan severance was calculated using the actual amount awarded under the 2021 AIP. There can be no assurance that the event triggering payments would produce the same or similar results as those described below if such event occurs on any other date or at any other price, or if any other assumption used to estimate the potential payments and benefits is incorrect. Any actual payments and benefits may be different due to a number of factors that affect the nature and amount of any potential payments or benefits.

Name | Benefit | Termination Without Cause or For Good Reason ($) | Termination Without Cause or For Good Reason Following a Change in Control ($) | Termination following Death ($) | Termination following Disability ($) | Termination following Non- Renewal ($)
Eugene A. Scherbakov | Salary Severance and Benefits Continuation | 1,294,860 | 1,726,479 | — |  | — |  | 863,240
Incentive Plan Severance | 1,919,896 | 2,639,602 | 1,919,896 | 1,919,896 | 1,919,896
Equity Acceleration(1) | 3,450,485 | 12,175,427 | 12,175,427 | — |  | — |
Total | 6,665,241 | 16,541,508 | 14,095,323 | 1,919,896 | 2,783,136
Timothy P.V. Mammen | Salary Severance and Benefits Continuation | 796,486 | 1,061,981 | — |  | — |  | 530,990
Incentive Plan Severance | 909,600 | 1,366,827 | 909,600 | 909,600 | 909,600
Equity Acceleration(1) | 1,638,746 | 5,492,274 | 5,492,274 | — |  | — |
Total | 3,344,832 | 7,921,082 | 6,401,874 | 909,600 | 1,440,590
Angelo P. Lopresti | Salary Severance and Benefits Continuation | 683,100 | 910,800 | — |  | — |  | 455,400
Incentive Plan Severance | 819,700 | 1,225,047 | 819,700 | 819,700 | 819,700
Equity Acceleration(1) | 1,415,034 | 4,640,379 | 4,640,379 | — |  | — |
Total | 2,917,834 | 6,776,226 | 5,460,079 | 819,700 | 1,275,100
Alexander Ovtchinnikov | Salary Severance and Benefits Continuation | 699,589 | 932,785 | — |  | — |  | 466,393
Incentive Plan Severance | 812,100 | 1,213,780 | 812,100 | 812,100 | 812,100
Equity Acceleration(1) | 1,401,960 | 4,597,962 | 4,597,962 | — |  | — |
Total | 2,913,648 | 6,744,527 | 5,410,062 | 812,100 | 1,278,493
Felix Stukalin | Salary Severance and Benefits Continuation | 686,804 | 915,738 | — |  | — |  | 457,869
Incentive Plan Severance | 794,900 | 1,187,927 | 794,900 | 794,900 | 794,900
Equity Acceleration(1) | 1,380,503 | 4,595,015 | 4,595,015 | — |  | — |
Total | 2,862,207 | 6,698,680 | 5,389,915 | 794,900 | 1,252,769

(1)Equity acceleration is calculated at the full value of service-based RSUs. PSUs are presented at the maximum possible amount of shares. Values use the closing common stock price on December 31, 2021, of $172.14 per share and the aggregate difference between the exercise prices of outstanding stock options and the closing common stock price on December 31, 2021. Includes PSUs vesting on March 1, 2022 for Dr. Scherbakov, Messrs. Mammen and Lopresti, Dr. Ovtchinnikov and Mr. Stukalin with values of $2,139,356, $1,112,024, $900,636, $892,374, and $873,438, respectively, calculated pursuant to SEC rules, which did not meet the minimum performance threshold and resulted in no actual payout on March 1, 2022.
59

Executive Compensation Tables
CEO Pay Ratio
As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(u) of Regulation S-K, we are providing the following information on the relationship of the annual total compensation of our employees and the annual total compensation of Dr. Eugene Scherbakov, our CEO.
Determining our Median Employee: As permitted by SEC rules, because there has been no change in our employee population or employee compensation arrangements that we believe would significantly impact the pay ratio disclosure, the Company determined to use the same median employee in our pay ratio calculation as was used in the proxy statement for the 2021 annual meeting of stockholders.
Calculating the Pay Ratio: As required by the SEC rules, we calculated our median employee’s total annual compensation in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K (which is the calculation method for reporting CEO compensation in the Summary Compensation Table). The total compensation of our median employee was $44,504.
With respect to the annual total compensation of our CEO, we annualized the compensation of our current CEO (2021 base salary and annual bonus earned in respect of 2021 performance), who was appointed as of May 4, 2021, and otherwise included the amounts set forth for him in the Summary Compensation Table above. We determined that the 2021 annualized total compensation of our CEO was $7,539,939. As a result, the estimated ratio of the annual total compensation of our CEO to median employee in 2021 was approximately 169 to 1.
The pay ratio included in this information is a reasonable estimate calculated in a manner consistent with rules promulgated by the SEC. This information is being provided solely for compliance with SEC disclosure rules. The Compensation Committee does not consider this ratio when evaluating compensation arrangements.
60 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Proposal 2 | Ratify Deloitte & Touche LLP as Our Independent Registered Public Accounting Firm for 2022

Deloitte & Touche LLP currently serves as our independent registered public accounting firm and audited our consolidated financial statements for the year ended December 31, 2021. Our Audit Committee has appointed Deloitte & Touche LLP to serve as our independent registered public accounting firm for 2022, and to conduct an integrated audit of our consolidated financial statements for the year ending December 31, 2022 and of our internal control over financial reporting as of December 31, 2022. Deloitte & Touche LLP has served as the Company’s auditor since 1999. A representative of Deloitte & Touche LLP will attend the Annual Meeting where he or she will have the opportunity to make a statement, if he or she desires, and will be available to respond to appropriate stockholder questions.
The Audit Committee is solely responsible for the appointment, retention, termination and oversight of the work of our independent registered public accounting firm, including the approval of all engagement fees, terms, and the annual audit plan. In determining whether to reappoint Deloitte & Touche LLP as the Company’s independent external auditor, the Audit Committee took into consideration several factors, including an assessment of the professional qualifications and past performance of the lead audit partner and the Deloitte & Touche LLP team, the quality and level of transparency of the Audit Committee’s relationship and communications with Deloitte & Touche LLP. The Audit Committee considered, among other things, the knowledge and skills of Deloitte & Touche LLP’s auditing experts that would be providing services to the Company, international scope and knowledge of the Company and its operations. After its assessment, the Audit Committee concluded that the best course of action was to reappoint Deloitte & Touche LLP as the Company’s independent external auditor for 2022. Lead and concurring audit partners are subject to rotation requirements that limit the number of consecutive years an individual partner may provide services. The maximum number of consecutive years of service in that capacity is five years and 2024 is a year of lead audit partner rotation. The process for rotation of the Company's lead audit partner involves an inquiry into the backgrounds and experiences of several potential lead partners, a narrowing of the list to one or more, a meeting between the candidate or candidates for the role with the Chair of the Audit Committee, as well as with management. This is accompanied by several discussions with and a final approval by the entire Audit Committee.
Fees Paid to Deloitte & Touche. The fees for services provided by Deloitte & Touche LLP, member firm of Deloitte Touche Tohmatsu, and their respective affiliates, to the Company were:

| Fees
Fee Category | 2021 |  | 2020 |
Audit fees | $ | 2,230,305 |  | $ | 2,247,738 |
Audit-related fees | — | —
Tax fees | 235,195 | 145,000
All other fees | — | —
Total Fees | $ | 2,465,500 |  | $ | 2,392,738 |

Audit fees. These fees comprise fees for professional services rendered in connection with the audit of the Company’s consolidated financial statements that are customary under auditing standards generally accepted in the United States. Audit fees also include fees for consents and reviews related to SEC filings and quarterly services with respect to the preparation of our unaudited quarterly financial statements.
Audit-related fees. These fees comprise fees for services that are reasonably related to the performance of the audit or review of the Company’s financial statements.
61

Proposal 2 Ratify Deloitte & Touche LLP as Our Independent Registered Public Accounting Firm for 2022
Tax fees. Fees for tax services consist of fees for tax compliance services and tax planning and advice services. Tax compliance services are services rendered based upon facts already in existence or transactions that have already occurred to document, compute and obtain government approval for amounts to be included in tax filings. Tax planning and advice are services rendered with respect to proposed transactions or that alter a transaction to obtain a particular tax result.
All other fees. These are fees for any services not included in the other three categories.
Policy on Pre-Approval of Audit and Permissible Non-Audit Services. The Audit Committee pre-approves all audit and permissible non-audit services provided by the independent registered public accounting firm. These services may include audit services, audit-related services and tax services as well as specifically designated non-audit services that, in the opinion of the Audit Committee, will not impair the independence of the independent registered public accounting firm. Pre-approval is generally provided for each fiscal year, and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The independent registered public accounting firm and our management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent registered public accounting firm in accordance with the pre-approval, including the fees for the services performed to date. In addition, the Audit Committee also may pre-approve particular services on a case-by-case basis, as required. All of the services performed by Deloitte & Touche LLP in 2021 were pre-approved by the Audit Committee.
Our Audit Committee is solely responsible for selecting and appointing our independent registered public accounting firm, and this appointment is not required to be ratified by our stockholders. However, our Audit Committee has recommended that the Board submit this matter to the stockholders in a non-binding advisory vote as a matter of good corporate practice. If the stockholders fail to ratify the appointment, the Audit Committee will reconsider whether to retain Deloitte & Touche LLP, and may retain that firm or another without re-submitting the matter to our stockholders. Even if the appointment is ratified, the Audit Committee may, in its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and our stockholders.

Our Board of Directors Recommends a vote FOR ratification of Deloitte & Touche LLP as our independent registered public accounting firm for 2022.

62 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Audit Committee Report

The primary role of the Audit Committee is to assist the Board in fulfilling its oversight responsibilities by reviewing the financial information proposed to be provided to stockholders and others, the adequacy of the system of internal control over financial reporting and disclosure controls and procedures established by management and the Board, and the audit process and the independent registered public accounting firm’s qualifications, independence and performance.
Management has primary responsibility for the financial statements and is responsible for establishing and maintaining the Company’s system of internal controls over preparation of the Company’s financial statements. The Company’s independent registered public accounting firm, Deloitte & Touche LLP, is responsible for performing an integrated audit of the Company’s consolidated financial statements and the effectiveness of internal controls over financial reporting in accordance with standards of the Public Company Accounting Oversight Board (United States) ("PCAOB") and issuing an opinion on the financial statements and the effectiveness of internal controls over financial reporting. The Audit Committee also employs an international auditing firm to conduct internal audits throughout the Company of various financial, operational and information technology areas as selected each year by the Audit Committee. The Audit Committee periodically met and held separate discussions with the internal auditors and the Company’s independent registered public accounting firm, with and without management present, to review the adequacy of the Company’s internal controls, financial reporting practices and audit process.
The Audit Committee has reviewed and discussed the Company’s audited consolidated financial statements for the year ended December 31, 2021 with management. In addition, the Audit Committee has discussed with Deloitte & Touche LLP the matters required to be discussed by the applicable requirements of the PCAOB and the SEC.
The Audit Committee also has received the written disclosures and the letter from Deloitte & Touche LLP required by the applicable requirements of the PCAOB regarding the independent registered public accounting firm’s communications with the Audit Committee concerning independence, and the Audit Committee has discussed the independence of Deloitte & Touche LLP with that firm. The Audit Committee also has considered whether Deloitte & Touche LLP’s provision of non-attest services to the Company is compatible with maintaining the auditors’ independence.
Based on the above-mentioned reviews and discussions, the Audit Committee recommended to the Board that the Company’s audited consolidated financial statements be included in its Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC.
AUDIT COMMITTEE
Thomas J. Seifert, Chair
Jeanmarie F. Desmond
Gregory P. Dougherty
March 16, 2022
The information in the Audit Committee Report shall not be considered “soliciting material” or “filed” with the SEC, nor shall this information be incorporated by reference into any previous or future filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company incorporated it by specific reference.
63

Common Stock Ownership

The following table provides information about the beneficial ownership of our common stock as of April 1, 2022 by:
•each NEO,
•each person who is a director or nominee,
•all executive officers and directors as a group and
•each person or entity known by us to own beneficially more than five percent of our common stock.
Percentage of beneficial ownership is based on 52,542,466 shares of common stock outstanding as of April 1, 2022.

Name(1) | Shares Owned | Right to Acquire Shares within 60 Days | Total Beneficial Ownership(2) | Percent
Michael C. Child(3) | 53,083 | 18,279 | 71,362 | *
Jeanmarie F. Desmond | 1,065 | 600 | 1,665 | *
Gregory P. Dougherty | 3,097 | 4,460 | 7,557 | *
Angelo P. Lopresti(4)(5) | 16,300,534 | 30,147 | 16,330,681 | 31.1 | %
Timothy P.V. Mammen | 39,105 | 13,133 | 52,238 | *
Eric Meurice | 10,817 | 21,202 | 32,019 | *
Alexander Ovtchinnikov(4) | 16,022,649 | 18,457 | 16,041,106 | 30.5 | %
Natalia Pavlova(6) | 931,535 | 15,864 | 947,399 | 1.8 | %
John R. Peeler | 2,939 | 8,777 | 11,716 | *
Eugene Scherbakov(4)(7) | 15,992,124 | 69,727 | 16,061,851 | 30.5 | %
Thomas J. Seifert | 5,114 | 2,314 | 7,428 | *
Felix Stukalin | 16,856 | 44,516 | 61,372 | *
Agnes K. Tang | — | — | — | *
All executive officers and directors as a group (15 persons) | 17,453,693 | 257,524 | 17,711,217 | 33.5 | %
Other >5% Stockholders |  |  |  |
Valentin Gapontsev Trust I(1)(8) | 14,353,603 | — | 14,353,603 | 27.3 | %
IP Fibre Devices (UK) Ltd.(1)(7) | 6,914,004 | — | 6,914,004 | 13.2 | %
The Vanguard Group(9) | 3,825,075 | — | 3,825,075 | 7.3 | %
AllianceBernstein L.P.(10) | 3,400,502 | — | 3,400,502 | 6.5 | %

* Less than 1.0%
(1)The contact address for each person or entity is in care of IPG Photonics Corporation, 50 Old Webster Road, Oxford, Massachusetts 01540.
(2)In accordance with SEC rules, beneficial ownership includes any shares for which a person or entity has sole or shared voting power or investment power and any shares for which the person or entity has the right to acquire beneficial ownership within 60 days after April 1, 2022 through the exercise of any option or the vesting of a RSU or a PSU.
(3)Includes 3,274 shares held in the name of Jewell Partners LLC, in which Mr. Child is partial owner and Managing Member, and 1,638 shares held by TA Money Purchase Plan for the benefit of Mr. Child.
(4)Includes (a) 7,439,599 shares owned of record by Valentin Gapontsev Trust I (“Gapontsev Trust I”), (b) 6,914,004 shares owned of record by IP Fibre Devices (UK) Ltd. ("IPFD") which may be deemed to be beneficially owned by Gapontsev Trust I (see notes 7 and 8 below), (c) 674,891 shares beneficially owned by Valentin Gapontsev Trust II (“Gapontsev Trust II”), and (d) 938,750 shares beneficially owned by Valentin Gapontsev Trust III (“Gapontsev Trust III”), because such person is a trustee of each trust. Gapontsev Trust I, Gapontsev Trust II and Gapontsev Trust III were formed by the late founder of the Company and former Executive Chairman of the Board, Valentin Gapontsev.
(5)Mr. Lopresti is a trustee of the Valentin Gapontsev Trust Agreement, a trust formed by Valentin Gapontsev. In such role he may be deemed the beneficial owner of 298,638 shares owned by the trust. He disclaims beneficial ownership of the shares held by the trust.
64 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Common Stock Ownership
(6)Ms. Pavlova is the wife of Dr. Igor Samartsev, the Company's Senior Vice President, Chief Scientist. Under SEC rules, the shares beneficially owned by each are deemed to be beneficially owned by the other. Also includes 10,000 shares held by Ms. Pavlova’s mother. Ms. Pavlova and Dr. Samartsev disclaim beneficial ownership of such shares.
(7)Dr. Scherbakov is the sole managing director of IPFD and has sole voting and investment power with respect to the shares held of record by IPFD. The following officers and directors of the Company or related parties have economic interests in IPFD: Gapontsev Trust I (48%), Mr. Samartsev (8%), Dr. Scherbakov (8%), the Estate of Valentin Gapontsev (3%) and Gapontsev Trust III (2%). Each such person and entity (other than Dr. Scherbakov) does not possess voting or investment power with respect to such interest and each disclaims beneficial ownership of the shares held by IPFD except to the extent of his or its economic interest therein.
(8)Includes 6,914,004 shares beneficially owned by IPFD, in which Gapontsev Trust I has a 48% economic interest. Gapontsev Trust I disclaims beneficial ownership of the shares held by IPFD except to the extent of its economic interest therein. See note 7 above.
(9)The address of The Vanguard Group is 100 Vanguard Boulevard, Malvern, PA 19355. Based solely on a Schedule 13G/A filed with the SEC on February 10, 2022.
(10)The address of AllianceBernstein L.P. is 1345 Avenue of the Americas, New York, NY 10105. Based solely on a Schedule 13G filed with the SEC on February 14, 2022.
65

Questions and Answers About the Meeting and Voting

When and Where Is the Annual Meeting?

WHEN: Tuesday, May 24, 2022, at 10:00 a.m. Eastern Time | WHERE: IPG Photonics Corporation 50 Old Webster Road Oxford, Massachusetts 01540

What is the Impact of COVID-19 on the Annual Meeting?
We currently intend to hold the Annual Meeting in person. We are monitoring the recommendations and protocols issued by public health authorities and federal, state, and local governments in response to COVID-19. If we determine that alternative Annual Meeting arrangements are advisable or required, which may include switching to a virtual meeting format, or changing the time, date or location of the Annual Meeting, then we will announce our decision via press release and the filing of additional proxy materials with the SEC. Please monitor our investor website at investor.ipgphotonics.com in advance of the Annual Meeting date if you are planning to attend in person. Please note that: (i) we will not be serving food and drink as we had in past years and (ii) we do not intend to have a presentation concerning the results from 2021.
What is the Purpose of These Materials?
The Board is soliciting proxies from our stockholders in connection with our annual meeting of stockholders to be held on Tuesday, May 24, 2022 and any and all adjournments thereof. This Proxy Statement and our Annual Report are first being made available to stockholders of record on or about April 14, 2022 at investor.ipgphotonics.com. Information on the website does not constitute part of this Proxy Statement. Unless otherwise noted, the information in this Proxy Statement covers our 2021 fiscal year, which ran from January 1, 2021 through December 31, 2021.
What Matters Am I Being Asked to Vote On at the Meeting and What Vote is Required to Approve Each Matter?
You are being asked to vote on two proposals.
Proposal 1 requests the election of directors named in this Proxy Statement. Our bylaws require that, in uncontested elections, each director be elected by the majority of votes cast with respect to such director. This means that the number of shares voted “for” a director nominee must exceed the number of votes cast “against” that nominee in order for that nominee to be elected. Only votes “for” or “against” are counted as votes cast with respect to a director. Abstentions and broker non-votes (as defined below) will have no effect on Proposal 1. To be elected in a “contested election” of directors, which our bylaws define as an election in which the number of nominees for director is greater than the number of directors to be elected, as determined as of the tenth day preceding the date the Company first mails its notice of meeting to stockholders, a director nominee must receive a plurality of the votes cast. The election of directors at the Annual Meeting is an uncontested election.
Proposal 2 requests the ratification of the appointment of our independent registered public accounting firm for 2022.
The affirmative vote of the holders of a majority of the outstanding shares which are present at the meeting in person or by proxy, and entitled to vote thereon, is required for approval of Proposal 2. Abstentions have the same effect as voting against Proposal 2. Because Proposal 2 is considered a “routine” matter, broker non-votes are not expected to occur with respect to this Proposal.
No business can be conducted at the Annual Meeting unless a majority of all outstanding shares entitled to vote are either present in person or represented by proxy at the meeting. As far as we know, the only matters to be brought before the Annual Meeting are those referred to in this Proxy Statement. If any additional matters are presented at the Annual Meeting, the persons named as proxies may vote your shares in their discretion.
66 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Questions and Answers About the Meeting and Voting
What Happens if a Director Nominee Fails to Receive a Majority Vote in an Uncontested Election at the Annual Meeting?
If a nominee who currently is serving as a director does not receive the affirmative vote of at least a majority of the votes cast in an uncontested election, Delaware law provides that the director would continue to serve on the Board as a “holdover director.” However, under our bylaws, each incumbent director is required to submit a letter of resignation as a condition of becoming a nominee of the Board, with the resignation contingent upon not receiving a majority of the votes cast in an uncontested election and acceptance of the resignation by the Board. In such event, the NCGC (or another committee designated by the Board) would make a recommendation to the Board as to whether to accept or reject the tendered resignation, or whether other action should be taken. The Board would act on the tendered resignation, taking into account the committee’s recommendation, and would publicly disclose its decision regarding the resignation within 90 days after the results of the election are certified. If the resignation is not accepted, the director would continue to serve until the next annual meeting of stockholders and until the director’s successor is elected and qualified.
Who Is Entitled to Vote at the Annual Meeting?
You are entitled to vote at the Annual Meeting if you owned shares of IPG (directly or in “street name,” as defined below) as of the close of business on April 1, 2022, the record date for the Annual Meeting. On that date, 52,542,466 shares of our common stock were outstanding and entitled to vote and no shares of our preferred stock were outstanding. Each share of our common stock is entitled to one vote with respect to each matter on which it is entitled to vote. There is no cumulative voting with respect to any proposal.
What Do I Need to Do If I Plan to Attend the Annual Meeting in Person?
If you plan to attend the Annual Meeting in person, you must provide proof of your ownership of our common stock and a form of personal identification, such as a driver’s license, for admission to the Annual Meeting. If you are a stockholder of record, the top half of your proxy card is your admission ticket and will serve as proof of ownership. If you hold your shares in street name, a recent brokerage statement or a letter from your bank or broker are examples of proof of ownership. If you hold your shares in street name and you also wish to be able to vote at the Annual Meeting, you must obtain a proxy, executed in your favor, from your bank or broker. We will not admit to the meeting persons or entities not having the required proof of ownership.
What Is the Difference Between Holding Shares Directly as a Stockholder of Record and Holding Shares in “Street Name” at a Bank or Broker?
Most of our stockholders hold their shares directly through a broker, bank or other nominee rather than directly in their own name. As summarized below, there are differences between shares held of record and those held in “street name.”
Stockholder of Record: If your shares are registered directly in your name with our transfer agent, Computershare, N.A., you are considered the stockholder of record with respect to those shares, and the Proxy Statement and Annual Report were sent directly to you. As the stockholder of record, you have the right to vote your shares as described herein.
“Street Name” Stockholder: If your shares are held by a bank, broker or other nominee on your behalf, you are considered the beneficial owner of shares held in “street name,” and the Proxy Statement and Annual Report were forwarded to you by your bank, broker or other nominee who is considered the stockholder of record with respect to those shares. Your bank, broker or other nominee sent to you, as the beneficial owner, a document describing the procedure for voting your shares. You should follow the instructions provided by your bank, broker or other nominee to vote your shares. You are also invited to attend the Annual Meeting. However, if you wish to be able to vote at the meeting, you must obtain a proxy card, executed in your favor, from your bank, broker or other nominee.
What Does it Mean to Give a Proxy?
Your properly completed proxy/voting instruction card will appoint Eugene Scherbakov and Angelo P. Lopresti as proxy holders or your representatives to vote your shares in the manner directed therein by you. Dr. Scherbakov is our CEO. Mr. Lopresti is our Senior Vice President, General Counsel and Secretary. Your proxy permits you to direct the proxy holders to vote “For,” “Against,” or “Abstain” for each of the proposals included in this Proxy Statement.
All of your shares entitled to vote and represented by a properly completed proxy or voting instruction received prior to the Annual Meeting and not revoked will be voted at the meeting in accordance with your instruction.
67

Questions and Answers About the Meeting and Voting
What Happens If I Sign, Date and Return My Proxy But Do Not Specify How I Want My Shares Voted on One of the Proposals?
Stockholder of Record: Your proxy will be counted as a vote “For” all of the nominees for director (Proposal 1) and “For” the ratification of the appointment of our independent registered public accounting firm (Proposal 2).
“Street Name” Stockholder: Your bank, broker or nominee may vote your shares only on those proposals on which it has discretion to vote. Under the rules that govern brokers who are voting with respect to shares held in street name, brokers have the discretion to vote those shares on routine matters, such as the vote to ratify the appointment of our independent registered public accounting firm (Proposal 2), but not on non-routine matters, such as the election of directors (Proposal 1). Accordingly, if you do not give your bank, broker or nominee specific instructions with respect to Proposal 2, your shares will be voted in such entity’s discretion (but only with respect to Proposal 2). We urge you to promptly provide your bank, broker or nominee with appropriate voting instructions so that all of your shares may be voted at the Annual Meeting.
Can I Change My Vote Before the Annual Meeting?
You can change your vote at any time before your proxy is exercised by delivering a properly executed, later-dated proxy (including an Internet or telephone vote), by revoking your proxy by written notice to the Secretary of IPG, or by voting in person at the Annual Meeting. If you choose to revoke your proxy by attending the Annual Meeting, you must vote your shares for revocation to be effective. The method by which you vote by a proxy will in no way limit your right to vote at the meeting if you decide to attend in person.
If your shares are held in street name, please refer to the information forwarded by your bank, broker or nominee for procedures on changing your voting instructions.
Is the Proxy Statement Available on the Internet?
Yes. We are delivering this Proxy Statement and the Annual Report pursuant to the SEC rules that allow companies to furnish proxy materials to their stockholders over the Internet. On or about April 14, 2022, we will mail to our stockholders a notice (the “Notice”) containing instruction on how to access this Proxy Statement and the Annual Report and to vote via the Internet or by telephone. Stockholders can view these documents on the Internet by accessing the website at investor.ipgphotonics.com.
What Does it Mean If I Receive More Than One Notice of Internet Availability of Proxy Materials?
You may receive more than one Notice, more than one e-mail or multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you may receive a separate Notice, a separate e-mail or a separate voting instruction card for each brokerage account in which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you may receive more than one Notice, more than one e-mail or more than one proxy card.
To vote all of your shares by proxy, you must complete, sign, date and return each proxy card and voting instruction card that you receive and vote over the Internet the shares represented by each Notice that you receive (unless you have requested and received a proxy card or voting instruction card for the shares represented by one or more of those Notices).
Who Is Soliciting My Proxy and Who is Paying for the Cost of This Proxy Solicitation?
The Board of IPG is soliciting your proxy to vote at the Annual Meeting. IPG will bear the expense of preparing, posting to the Internet, printing and mailing proxy materials, as well as the cost of any required solicitation. We may also reimburse banks, brokers and other custodians, nominees and fiduciaries for reasonable expenses incurred in forwarding proxy materials to beneficial owners of our stock and obtaining their proxies. In addition to the mailing of proxy materials, the solicitation of proxies may be made in person, by telephone, or by electronic communication by our directors, officers or employees, without additional compensation, on our behalf.
68 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Questions and Answers About the Meeting and Voting
Who Counts the Votes?
We have engaged Computershare, N.A. as our independent agent to receive and tabulate stockholder votes. Computershare, N.A. will separately tabulate “For” and “Against” votes, abstentions and broker non-votes. Computershare, N.A. will also act as independent election inspector to certify the results, determine the existence of a quorum and the validity of proxies and ballots, and perform any other acts required under the General Corporation Law of Delaware.
How Can I Vote?
Most stockholders have a choice of voting in one of four ways:
•via the Internet
•using a toll-free telephone number
•completing a proxy/voting instruction card and mailing it in the postage-paid envelope provided or
•in person at the meeting.
The telephone and Internet voting facilities for stockholders of record will close at 1:00 a.m. Central Time on May 24, 2022. The Internet and telephone voting procedures are designed to authenticate stockholders by use of a control number and to allow you to confirm that your instructions have been properly recorded.
If you hold your shares in “street name,” your bank, broker or other nominee will send you a separate package describing the procedures and options for voting your shares. Please read this information carefully. If you hold your shares in “street name,” and wish to vote in person at the Annual Meeting, you must obtain a “legal proxy” from the organization that holds your shares. A legal proxy is a written document that will authorize you to vote your shares held in “street name” at the Annual Meeting. Please contact the organization that holds your shares for instructions regarding obtaining a legal proxy. You must bring a copy of the legal proxy to the Annual Meeting and ask for a ballot when you arrive.
What Is the Quorum Required to Transact Business?
At the close of business on April 1, 2022, the record date, there were 52,542,466 shares of our common stock outstanding. Our bylaws require that a majority of our common stock be represented, in person or by proxy, at the Annual Meeting in order to constitute the quorum we need to transact business at the meeting. We will count broker non-votes and proxies marked “abstain” as present in determining whether a quorum exists.
69

Additional Information

2023 Annual Meeting and Nominations
Stockholders may present proposals for action at a future meeting and nominations for director if they comply with applicable SEC rules and our bylaws. Proposals and director nominations must be received by our Secretary at IPG Photonics Corporation, 50 Old Webster Road, Oxford, Massachusetts 01540.
Matters for Inclusion in the Proxy Materials for the 2023 Annual Meeting of Stockholders. If you would like us to consider including a proposal in our proxy statement pursuant to Rule 14a-8 under the Exchange Act, it must be received by our Secretary on or before December 15, 2022.
Matters for Consideration at the 2023 Annual Meeting of Stockholders, but not for Inclusion in the Proxy Materials. If you would like to present a proposal at the 2023 annual meeting of stockholders, but not to have such proposal included in our proxy statement relating to that meeting, such proposal or nomination must be received by our Secretary not earlier than January 24, 2023 and not later than February 23, 2023.
Nominations of Individuals for Election as Directors at the 2023 Annual Meeting of Stockholders Using Proxy Access. A stockholder, or group of up to 20 stockholders, that has owned at least three percent of the Company’s outstanding common stock continuously for at least three years through the dates specified in the Company’s bylaws may nominate and include in the Company’s annual meeting proxy materials director nominees constituting up to the greater of two director nominees or 20 percent of the number of directors up for election, provided that the stockholder(s) and nominee(s) satisfy the requirements in specified in our bylaws. Notice of proxy access director nominees must be received by our Secretary not earlier than November 15, 2022 and not later than December 15, 2022.
Nominations of Individuals for Election as Directors at the 2023 Annual Meeting of Stockholders, but not Included in the Proxy Materials. If you would like to nominate a director next year, but not to have such nominee included in our proxy statement relating to that meeting, such nomination must be received by our Secretary not earlier than January 24, 2023 and not later than February 23, 2023.
Universal Proxy Rules at the 2023. In addition to satisfying the foregoing requirements, to comply with the universal proxy rules (once they become effective), stockholders who intend to solicit proxies in support of director nominees other than the Company's nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than March 27, 2023.
Additional Requirements. Our bylaws contain specific requirements regarding a stockholder’s ability to nominate a director or to submit a proposal for consideration at an upcoming meeting. A stockholder who wishes to nominate a director or to submit a proposal for consideration is encouraged to read our bylaws carefully and to seek independent counsel about our bylaws and SEC requirements. If the NCGC or the Board determines that any nomination or proposal made by a stockholder was not made in accordance with the Company’s procedures, the rules and regulations of the SEC or other applicable laws or regulations, such nomination or proposal would be void. If you would like a copy of the requirements contained in our bylaws, please contact our Secretary.
No Incorporation by Reference
In our filings with the SEC, information is sometimes “incorporated by reference.” This means that we are referring you to information that has previously been filed with the SEC and the information should be considered as part of the particular filing. As provided under SEC regulations, the Compensation Committee Report and the Audit Committee Report contained in this Proxy Statement specifically are not incorporated by reference into any of our other filings with the SEC, are not to be deemed soliciting materials or subject to the liabilities of Section 18 of the Exchange Act. In addition, this Proxy Statement includes several website addresses. These website addresses are intended to provide inactive, textual references only. The information on these websites is not part of this Proxy Statement.
70 NOTICE OF 2022 ANNUAL MEETING AND PROXY STATEMENT

Additional Information
Stockholders Sharing the Same Address
Under the rules adopted by the SEC, we may deliver a single set of proxy materials to one address shared by two or more of our stockholders. This delivery method is referred to as “householding”. This procedure reduces the environmental impact of our annual meeting and the costs of printing and mailing. To take advantage of this opportunity, we have delivered only one set of proxy materials to multiple stockholders who share an address, unless we received contrary instructions from the impacted stockholders prior to the mailing date. If you wish to receive a separate copy of the Proxy Statement and annual report or if you wish to receive separate copies of future annual reports and proxy statements, then call 877-373-6374.
If you hold your shares in “street name”, contact your bank or broker to request information about how to eliminate duplicate mailings.
71